Podcasts about Johns Hopkins Hospital

It's back-to-school szn, and while some kids are stressing over earlier wake-ups, this year's incoming medical students have a bigger question to answer: how do you train for a career that could still have you practicing medicine in the 2070s, when the tools of medicine are changing so rapidly?For our back-to-school episode, we sat down with Stanford University School of Medicine Dean Dr. Lloyd Minor to talk about how AI is already reshaping what future doctors learn and how they're taught, as well as what's still not working in American healthcare.We cover:What medical students are actually being taught about AI, and where Stanford still draws the lineWhy Stanford's tumor boards no longer start with humansThe surprising way Dr. Minor thinks AI could level the playing field in healthcare accessWhy the same AI tools helping patients feel more informed are also making them more anxiousThe counterintuitive reason new medical technology gets more expensive before it gets cheaperWhat's still standing in the way of a vision for precision medicine that's been decades in the makingAbout our guest:Lloyd B. Minor, MD, is a scientist, surgeon, and academic leader. He is the Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine and Vice President for Medical Affairs at Stanford University. Dr. Minor also is a professor of Otolaryngology–Head and Neck Surgery and a professor of Bioengineering and of Neurobiology, by courtesy, at Stanford University.As dean, Dr. Minor has had an integral role in setting strategy for the clinical enterprise of Stanford Medicine, an academic medical center that includes the Stanford University School of Medicine, Stanford Health Care, and Stanford Medicine Children's Health. With his leadership, Stanford Medicine leads the biomedical revolution in Precision Health. His book, “Discovering Precision Health,” describes this shift to more preventive, personalized health care and highlights how biomedical advances are dramatically improving our ability to treat and cure complex diseases. In 2021, Dr. Minor articulated and began realizing a bold vision to transform the future of life sciences at Stanford University and beyond – a multi-decade journey enabled by Precision Health.In August 2023, Dr. Minor was appointed Vice President for Medical Affairs to lead all matters related to health and medicine at Stanford University.Before Stanford, Dr. Minor was provost and senior vice president for academic affairs of Johns Hopkins University. Prior to this appointment in 2009, Dr. Minor served as the Andelot Professor and director (chair) of the Department of Otolaryngology–Head and Neck Surgery in the Johns Hopkins University School of Medicine and otolaryngologist-in-chief of The Johns Hopkins Hospital.With more than 160 published articles and chapters, Dr. Minor is an expert in balance and inner ear disorders perhaps best known for discovering superior canal dehiscence syndrome, a debilitating disorder characterized by sound- or pressure-induced dizziness. He subsequently developed a surgical procedure that corrects the problem and alleviates symptoms.In 2012, Dr. Minor was elected to the National Academy of Medicine.—

This episode's Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow' Sustainability Campaign, and how you can get involved: CLICK HEREEpisode Overview: American healthcare is at a crossroads, and the decisions we make now will define the health of generations to come.Dr. Marschall Runge has spent more than four decades at the center of that challenge, serving as former CEO of Michigan Medicine, Dean of the University of Michigan Medical School, and EVP for Medical Affairs.A practicing cardiologist trained at Johns Hopkins and Massachusetts General Hospital, Dr. Runge brings both the scientist's rigor and the leader's vision to one of the most urgent conversations of our time.In his Amazon and USA Today bestselling book, "The Great Healthcare Disruption," he lays out a bold prescription for reimagining American medicine through AI, innovation, and courageous systemic change.Join us to discover what it truly takes to transform healthcare from the inside out. Let's go!Episode Highlights:Dr. Runge never planned to be a CEO, initially dismissing healthcare leaders before serendipity shaped his path.His personal hospital-at-home experience after hip surgery confirmed that recovery is faster, cheaper, and better at home.Ambient AI, which auto-generates clinical notes, is the one decision at Michigan Medicine that faced almost no dissent.America's top-tier quaternary care leads the world; the real crisis is access, not quality.AI can address the clinician shortage in a year or two, something traditional training pipelines need decades to solve.About our Guest:Marschall S. Runge, M.D., Ph.D., was born in Austin, Texas, and graduated from Vanderbilt University with a BA in General Biology and a PhD in Molecular Biology. He received his medical degree from the Johns Hopkins School of Medicine and trained in internal medicine at Johns Hopkins Hospital. He was a cardiology fellow and junior faculty member at Massachusetts General Hospital. Dr. Runge's next position was at Emory University, where he directed the Cardiology Fellowship Training Program. He then moved to the University of Texas Medical Branch in Galveston, where he was Chief of Cardiology and Director of the Sealy Center for Molecular Cardiology. He joined the University of North Carolina (UNC) from 2000 – 2014, where he served as Charles Addison and Elizabeth Ann Sanders Distinguished Professor of Medicine, Chair of the Department of Medicine, President of UNC Physicians and Vice Dean for Clinical Affairs.Dr. Runge is the former CEO of Michigan Medicine and Dean of the University of Michigan Medical School, and a practicing cardiologist. Dr. Runge is board-certified in internal medicine and cardiovascular diseases and has spoken and published widely on topics in clinical cardiology and vascular medicine.At the University of Michigan, Dr. Runge began serving as the executive vice president for medical affairs in March 2015 and, in January 2016, he was also appointed as the dean of the Medical School. He is the first person to serve in this combined position created by the Regents for the purpose of strengthening the integration between the Medical School and health care delivery in our hospitals and health centers.During his tenure in these leadership roles, Dr. Runge has implemented transformative change and positioned Michigan Medicine and the Medical School for continued success. Notable achievements during this period include: a significant expansion of Michigan Medicine's clinical network in the state, through integration of two health systems, the former Metro Health in Grand Rapids and Sparrow Health System in Lansing, multiple joint ventures with Trinity Health, launch of the Precision Health Initiative, a major research collaboration with several other U-M schools and colleges; oversight of the conclusion of the Victors for Michigan campaign which raised $1.5 billion dollars for institutional strategic priorities; and the development and implementation of Michigan Medicine's first strategic plan for diversity, equity and inclusion in support of the broader university-wide DEI initiative.Under Dr. Runge's leadership, the University of Michigan Health's adult hospitals were ranked best in Michigan in 2023-2024 in U.S. News & World Report “Best Hospitals” rankings, the 31st consecutive year that U-M Health has been nationally recognized for strong across-the-board performance. In Newsweek's 2024 ranking of America's Best Hospitals, U-M Health ranked #1 in the state and #3 in the country.Current and new initiatives under Dr. Runge's leadership include construction of the The D. Dan and Betty Kahn Health Care Pavilion, a 12-story and 264 private room inpatient hospital; working to reduce faculty and staff burnout; executive rounding to help promote employee engagement and retention; establishment of the Heart Brain Institute and Global Health; oversight and development of the Anti-Racism Oversight Committee to help achieve an anti-racist culture; improved access and patient experience through the M2C2 Capacity Center; and the establishment of the Care at Home initiative which focuses on providing safe, hospital-level care to patients in their own home.Dr. Runge has been a physician-scientist for his entire career, combining basic and translational research with the care of patients with cardiovascular diseases and education. He is the author of over 200 publications in the field and holds five patents for novel approaches in health care.Links Supporting This Episode: Dr. Marschall Runge Website: CLICK HEREDr. Marschall Runge LinkedIn page: CLICK HEREThe Great Healthcare Disruption book link: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form: CLICK HERE

Dr. Lucy McBride is a primary care physician and co-founder of the Ackerly McBride Group in Washington, DC. For over 25 years, she has practiced evidence-based, relationship-centered medicine. A graduate of Princeton and Harvard Medical School, with a master's degree in Pharmacology from Cambridge as a Fulbright Scholar, she completed her internal medicine residency at Johns Hopkins Hospital. She writes the weekly newsletter Are You Okay? and hosts the podcast Beyond the Prescription. Her work has appeared in The Atlantic, The Washington Post, and USA Today. She has contributed to CNN, MSNBC, and PBS, advocating for a holistic, patient-centered approach to health. Her upcoming book Beyond the Prescription will be released August 11, 2026.In this conversation, we discussed how health isn't just about getting answers but about asking the right questions, what primary care physicians are doing for their patients in an ideal world vs. what is actually happening, why doctors should treat the whole patient and not just a set of symptoms, and her upcoming book Beyond the Prescription which includes a 5 step process for taking charge of your health.Connect with Lucy: Instagram | Website | Substack | Buy the Book If you're looking to unleash your potential, find your personal, professional, or political fire, and to connect with a community who is doing the same, click here to learn more. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit shannonwatts.substack.com/subscribe

Step into the crucial world of neonatal care with this episode of Legal Nurse Podcast, hosted by Pat Iyer and featuring neonatal nurse practitioner and expert witness Yana Felix. As medical knowledge and parental expectations continue to evolve, the first moments of a newborn's life are both medically and legally complex. Yana Felix, who practices at Johns Hopkins, shares clinical insights and legal pearls drawn from hands-on experience in newborn resuscitation, delivery room challenges, and the nuanced standards of care shaping today's neonatal outcomes. Together, discuss the foundational steps in newborn care, the critical reasoning behind interventions like vitamin K administration, and the intricacies of Apgar scoring. The conversation navigates real-world dilemmas such as parental refusal of standard treatments and the shifting recommendations of the Neonatal Resuscitation Program (NRP), offering valuable guidance for clinicians, legal nurse consultants, and attorneys who may one day analyze these cases. Whether you are a healthcare professional, legal expert, or a parent interested in understanding what happens in those vital first minutes of life, this episode will provide you with practical knowledge and a deeper appreciation for both the science and the stakes of neonatal care. What You'll Learn in This Episode on Vitamin K Refusals, Documentation Gaps, and Litigation Risks in Neonatal Care Here are 5 discussion questions answered in the podcast: Why is vitamin K administration at birth controversial among some parents, and what are the medical implications of refusing it? How are Apgar scores used to assess a newborn's health, and what red flags should be noted in medical records during legal reviews? What are the key updates from the 9th Edition of the Neonatal Resuscitation Program (NRP), and how do they impact clinical practice? How does delayed cord clamping benefit newborns, and what are the potential risks if not properly balanced with timely interventions? In what ways might documentation or lack thereof influence the legal outcomes of neonatal resuscitation cases? Get the free transcripts and also learn about other ways to subscribe. Go to Legal Nurse Podcasts subscribe options by using this short link: http://LNC.tips/subscribepodcast. https://youtu.be/GVsR5EOrJVU Your Presenter for Vitamin K Refusals, Documentation Gaps, and Litigation Risks in Neonatal Care Pat Iyer Pat Iyer is a seasoned legal nurse consultant and business coach, renowned for her expertise in guiding new legal nurse consultants to successfully break into the field. As the host of the Legal Nurse Podcast, Pat addresses critical challenges that legal nurse consultants face, such as difficulty in landing clients and a lack of response from attorneys. Through her insightful episodes, she emphasizes the importance of effectively communicating one's value to potential clients. With a wealth of experience, Pat has empowered countless consultants to overcome these hurdles and thrive in their careers. Connect with Pat Iyer by email at patiyer@legalnusebusiness.com Yana Felix Yana is a Neonatal Nurse Practitioner at Johns Hopkins Hospital, where she provides expert clinical care for critically ill newborns. She also serves as a Neonatal Nurse Practitioner legal consultant, sharing clinical knowledge for medicolegal review and education. When she is not on this podcast, Yana is enjoying art history, traveling, and exploring the world with her canine companion. Connect with Yana Felix by email at yfelix1@jh.edu

The period immediately after hospital discharge is a critical yet often overlooked phase in stroke recovery, marked by both heightened vulnerability and opportunities for rapid brain repair. This episode explores the concept of transitional stroke care, emphasizing early specialist follow up, coordinated multidisciplinary support, and targeted interventions to improve outcomes and reduce complications. In this episode, Katie Grouse, MD, FAAN, speaks with Mona N. Bahouth, MD, PhD, FAAN, author of the article "Transitional Stroke Care and the Road to Recovery" in the Continuum® June 2026 Cerebrovascular Disease issue. Dr. Grouse is a Continuum® Audio interviewer and a clinical assistant professor at the University of California, San Francisco in San Francisco, California. Dr. Bahouth is the medical director of the Brain Rescue Unit and an associate professor of neurology at Johns Hopkins School of Medicine in Baltimore, Maryland. Additional Resources Read the article: Transitional Stroke Care and the Road to Recovery Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Guest: @MonaBahouth Full episode transcript available here Dr Grouse: A lot of attention has been paid to what happens within hours to days of a stroke, but are we missing an equally crucial time in our patient's recovery after their discharge? Today, I have the opportunity to interview Dr. Mona Bahouth about the latest issue of Continuum on cerebrovascular disease.  Dr Jones: This is Dr. Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast.  Dr Grouse: This is Dr. Katie Grouse. Today, I'm interviewing Dr. Mona Bahouth about her article on transitional stroke care and the road to recovery. This article appears in the June 2026 Continuum issue on cerebrovascular disease. Welcome to the podcast, and please introduce yourself to our audience.  Dr Bahouth: Thank you for having me. I'm Mona Bahouth. I'm a stroke neurologist in Baltimore, Maryland, and I'm the medical director of our brain rescue unit at the Johns Hopkins Hospital. Great to be with you.  Dr Grouse: Thank you so much. This was a very interesting article. I have to confess going into it, I really didn't know a lot about transitional stroke care and the growing sort of recognition of its importance for stroke recovery and improved outcomes. Can you tell me what the key message from this article is that you really hope that readers will take away after reading it and hopefully integrate into their own patient practices?  Dr Bahouth: Yeah. I would say if there's one overarching message, it is that stroke care has come so far over the last couple of decades. We do so much wonderful life-saving work in the first couple of hours and days after stroke, but we haven't really paid as much attention to what happens once a patient leaves the hospital with this devastating acute disease. And I would just like to say that this article allows us to shine a light on providing a little bit more of a system of care, a more structured system of care that could benefit the patient for the long term, then that will benefit a large population of patients who otherwise may have complications that could cause disability longer in life.  Dr Grouse: Now, Mona, could you tell us in a nutshell, what is transitional stroke care, and why are we needing to focus more of our attention on this to improve patient recovery?  Dr Bahouth: Yeah. Over the last few years, we've really done a wonderful job of reducing the time that a patient spends in a hospital after stroke care. But in parallel, we have not really changed anything about what we do in the outpatient setting. So, a patient tells us that they come to the hospital with this acute and very scary and disabling disease. They feel that they're the center of the universe at our stroke centers, where we're hustling around them in groups and in interprofessional teams. But then on the day of discharge, they feel that they leave the hospital, and in some of our focus groups, that they kind of go home to a, a dark bedroom where they have to process all of this sort of on their own. It's quite a transition for both patients and their care partners. And here we've been very systematic about how we structure our care in the hospital for stroke patients, but once they leave the hospital, it's been a sort of free-for-all, or the Wild West, as some of my colleagues say. So transitional stroke care is really a way to extend the care that we deliver in the stroke unit to the patient's home or to their next phase of care. We know that stroke patients have 11 handoffs from beginning to end, in average, that they experience through the course of their acute stroke. And so, what we're really trying to do is extend the, the stroke unit to the patient's home or to their next phase of care so that they feel a bit more extension of that specialty care that they were receiving in the hospital. So, it's really a structure, a system.  Dr Grouse: Now, it seems that when we're thinking about the transitional care period, that it really hinges on this idea of sort of the sensitive period of stroke recovery. What is that, and why is that so important, and why do we really need to focus on that specific time?  Dr Bahouth: There are really two reasons that this is a critical period for patients. One is that we know from work in animal models as well as other sort of human early studies that the brain really has its optimal period of efficient brain repair in the first few weeks after stroke, meaning that it's recovering after this injury and figuring out how to reroute some really important brain functions. I would say it's also a critical period because the time period after stroke is a period that all the comorbid conditions that sort of conspired to cause a stroke are sometimes destabilized. And we know that sort of just putting people back on standard regimens for their hypertension, their diabetes, their heart failure doesn't always equate to sort of long-term improved outcomes at a time that the brain itself is going through changes. So, for example, we know that blood flow is critical to the brain. That's what all the hustle is about in the hyperacute period. And for the next couple of weeks after a stroke, autoregulation remains disrupted, so typical treatments of hypertension could have negative consequences for a subpopulation of patients. This management of hypertension needs to continue for a couple of days and weeks after stroke, and therefore, if a patient is discharged from the hospital, really requires a bit more specialty input. We also know that as the brain is trying to repair during the sensitive period, this high period of efficiency, we really want to inject high-intensity, high-quality activities that really improve their recovery. But in our current system in the United States, our transition to the period of rehabilitation is really quite clunky and disrupted and doesn't often happen in a seamless way. So, a true transitional stroke care program really attempts to manage the stroke itself. The comorbid conditions that conspire to cause the stroke, and the expedition of, of rehabilitation that could really jumpstart the recovery period in a more meaningful way.  Dr Grouse: Now, you mentioned hypertension as being sort of a critical factor that can affect the patients during this transitional period or this sensitive period. What are some other factors that can really play a huge part in their long-term outcomes in this really sensitive time?  Dr Bahouth: In our transitional stroke program, in our interprofessional group, we often talk about all of the changes that a patient is required to make at the time of stroke. Typically, they stay in the hospital several days. The patient and their care partner will receive a bolus of instructions about what their new healthier life should look like, and then they're sort of sent off to sort of self-manage without really accepting that that wasn't the perfect time to teach these things. So really, it's all about sort of lifestyle improvement. How do we get into a system of medication adherence when medications are a central portion of a patient's care? It is about managing the cognitive changes that happen after stroke, whether we acknowledge them in the hospital as a main deficit or something that people realize once they get back into the groove of their usual life, and the emotional consequences of stroke for both the patient and their care partner, who are both adjusting to this very scary moment that resulted in a brain injury. So, I think that the things that are focused on are both medical in terms of, you know, what are we doing with the diabetes? Is our glucose at a target range? Have we started wearing our sleep apnea paraphernalia? Are we managing our smoking cessation as much as we should? How have we done with our low-fat diet? Are we taking our medications as prescribed, or was there some cognitive blip that caused a mistake? But also sort of the emotional support that sometimes paralyze patients into sort of saying they cannot handle this transition into a new healthier way of brain recovery.  Dr Grouse: Yes, and it sounds like when patients sort of hit that wall, they almost just give up, right? There's just so many things they have to manage. They're emotionally trying to cope, and then they may eventually get to their neurologist at some point for a follow-up, and not much has happened.  Dr Bahouth: That's a really well-put statement. Like I mentioned earlier, we had several focus groups to say, "How's our stroke center doing? How is our comprehensive stroke center doing?" And we realized that we were very comprehensive while the patient was with us, but then the experience of the patient going home was really opposite of receiving comprehensive care. You know, the patient in the hospital said they felt well-supported, surrounded, quite busy all the time, but then they did go home, and this sort of set in that they've had a stroke. And many patients told us, "I just laid in bed because I couldn't quite kind of get through the thought that this has happened to me." And so, in our prior state of our comprehensive stroke system where patients weren't seen for a couple of months after their discharge, patients would tell me, "Well, I'm fine now.  But those first couple of months, I sure wasn't. You know, I was laying in bed. I was crying. I wasn't taking my medicines. I had a lot of despair and fear." Care partners would say, "I wasn't sleeping myself. I was watching to see if another stroke was gonna happen every minute." So, there are a lot of elements that are going on in those first two weeks that really require a specialist to say, "This is normal. This requires more attention," and to really help people get through a lot of the changes that come with stroke and brain injury.  Dr Grouse: Now, your article gave a really great, I think, example, where you had a juxtaposition of a hypothetical patient with a stroke and two very different post-discharge courses, one where they really kind of fell into that vacuum, that post-discharge vacuum, where they didn't get support and had some very disappointing outcomes versus a patient who did have a transitional care program with a lot of support post-discharge, and a lot of obstacles were overcome and problems solved such that the patient could do a lot better. And I encourage our listeners to take a look at it. If you could design and run it, how would your ideal transitional post-stroke program be structured? Like, how would you design it so that it would optimally support these patients?  Dr Bahouth: Yeah, you know, we, um, tangle with this every day in our current transitional stroke program that we call the JSTEP program. We've had several chapters of what we think is ideal for a patient, and thank you for sort of acknowledging that, like, the way those cases were written were really to underscore that we can have a lot of influence for patients. And while they were sort of hypothetical juxtapositions of one another, these are things we literally see every single day for our stroke patients. And people say, "Oh, if only we had done this, we would've caught that, and we would've prevented such-and-so." Some of the indicators of success have been we've really reduced our readmission rates to the hospital. We have decreased our length of stay because the confidence people feel to go home because they're well supported. So there have been indicators of success. But if I could take our program even next level, I would probably include a few other things. So currently, some of the strengths of the program are that a stroke specialist sees a patient within days of their discharge from the hospital, a time where some of those questions are sort of raising for the patient. Maybe a complication is starting to pop up that we can address before it, uh, gets out of hand and requires a readmission. We can tackle some of the fears that patients are having to say, "I wonder if this is normal or not. I better just go to the hospital." So, some of that early touch point by a true stroke specialist is really critical. And that visit only happens because the seed is planted in the hospital, so there really has to be some initiation of the program at the time the patient is in the hospital to say, "This is what you can expect when you leave here. You have someone who's walking this with you. They're a stroke specialist. They're gonna know how to help you navigate." The second part of our program that is a success is our rapid connection to specialties. So, we know that stroke patients are gonna need connection to rehabilitation specialists, physiatrists, the therapists. We know they're gonna need connection to cardiology when atrial fibrillation or heart failure or something is really at an extreme.We know endocrinology might be a part of the patient's story going forward. And so, I think the second success of our program is really alliance with key stakeholders in a stroke patient's life and quick access to having the patient be connected to what it is they need in the moment that we realize that there is a situation at home. The third thing that I think has been really a success of our program is this interprofessional education that we schedule patients for at the time of their discharge, just as any other important healthcare visit. During this interprofessional education session, the patients get to meet dietician, pharmacist, nurse, therapist, where key discussions about healthy behaviors, avoidance of complications after stroke really happen in a group session where there can be a lot of interaction. You know, currently our education happens in a time where the brain is injured, the patient is not sleeping well in the hospital. We have a lot of stress and fear. It's not the perfect time for anyone to receive such important education. So, I think the third really most important thing has been this formalized interprofessional education to really bolster the education that started at the hospital. If I were to really take our program next level, and every day we're considering it, I really think we haven't done a couple of key things. One is we have not really found a way for the care partner to be supported, that the care partner is usually the brave one sitting there with a tight lip and nodding and very, you know, concerned about what's happening and taking close notes. But we really haven't done well to just manage the care partner's needs sort of independently of the patient themselves, sort of help them with the experience of going through this. I think that could benefit both the care partner and the patient by sort of bolstering their sort of emotional consequences of this. And they are really our key partner in the patient's success in the outpatient setting, getting the patient motivated, helping them get to appointments, helping them to adhere with medications. So, I think if we can focus a bit more on the care partner, that might really bolster the long-term effect for patients. And I think finally, behavior change is very complex. Sometimes we're taking a group of patients who may have never exercised and said, "You know, we really... You need to walk several minutes a day. You need to increase your aerobic capacity. We need you to stop smoking." And these are not behavior changes that can just happen with sort of a one-time visit. So, I think we really need to incorporate a lot more of exercise therapy and concepts of people who can sort of coach along the continuum for some of these behavior changes so that we can really promote wellness and a return to health. And I think one final thing that could be additive from a transitional stroke program is really a better way to truly measure recovery for stroke patients, some of those in between the line measures that we're not really getting by a three-month modified Rankin score. I think a transitional stroke care model would really allow us to both insert research and potential other therapies along this time period, but also measure the success of those in a more granular way.  Dr Grouse: Thank you so much for that, and also it was really helpful to get a good overview of, like, what the transitional care program really means, right? Like, what is the structure? What is happening with the patient? So, I think all of that's really helpful. But I can't help but think, listening to all of that, that sounds like while certainly in an ideal state, and I don't think anyone can argue with how helpful that sounds, is it always something that's practical? Can we implement things like this, especially where access is limited, resources are dwindling as far as what patients can get and what evaluations patients can get? Do you think that this is something that can actually be implemented in programs throughout the country? And what are strategies we can consider to try to improve getting some of these resources for our patients?  Dr Bahouth: I think this is such a critical topic. I think that we have, in the medical system, tried to force our healthcare practices into old models of care instead of sort of adopting new ones. And so, I think that, you know, while everyone says, "Wow, that sounds like a very resource-rich program," I would have to stop and push back and say, well, a very resource-rich situation is when a stroke patient, sometimes fifteen to twenty percent of the time, are readmitted to the hospital at a time where hospital beds are at a premium. Maybe we need to turn those dollars of savings of sort of these readmissions and extra length of stay into dollars that we put into sort of this transitional period where we help promote success. So, I think it really becomes more of a value proposition when you talk about it. But that said, of course, we have to make sure that we're a high-value, high-productivity system. So, our current transitional care program uses a telemedicine structure. We know that stroke patients cannot drive in most states after their stroke. We know that their care partners are trying to return to work and normalize. It is very difficult for patients with paralysis, cognitive changes to come back and forth to multiple appointments. In the past, we have tried to make this transitional care program an in-hospital program. I think using the technologies that we have available for telemedicine are critical, especially for this population who have barriers to getting to their appointments. So, I think with a very low resource investment, a transitional care program can be created once you really develop the skills of the, the stroke team to really reach beyond the hospital with the tools that we already have in the hospital and just extend that to the next chapter. It is an investment, most certainly, but I think it's one well worth the investment for the patient's success, their quality of life, as well as some of the value metrics that we judge our hospitals by.  Dr Grouse: Are some of the transitional care codes that CMS has put out in recent years helpful to get some reimbursement for these types of visits?  Dr Bahouth: Absolutely. So, I think that's been a really wonderful policy change that has happened, recognizing the importance of these transitional care models. There are billing codes that allow you to have higher billing than a usual neurology appointment when a patient is within a certain window, meeting certain criteria for their eligibility for such a visit.There are codes that have now been developed and are being more and more utilized to have visits with care partners and realize that the care partner is an important member of the equation of this patient's success. So, there are definitely codes that can be used. I think we're very good in healthcare of delivering a lot of free care, but that's not the nature of the beast these days. We have to really be very aware of our dollars and cents, and so utilizing some of these important codes that I hope only continue to expand to recognize the importance of the transitional period for patients.  Dr Grouse: Now, Mona, I wanted to ask, was there anything that you wish you could have included in this article that didn't make it in?  Dr Bahouth: You know, obviously, um, word limitations are always challenging. I think that the article, I think, does a good job going sort of from beginning to end. I think a deeper section, certainly we have commented on the sort of sociodemographic challenges of a program like this that also relies on a technology like telemedicine in many cases. But there are so many nuances to that conversation that I think that section could have definitely gone on for a much longer period of time to talk about some of the strategies, the strategic ways that we work hard to make sure that these type of transitional care programs are accessible to all, especially the vulnerable who may have challenges with accessing technology. But I will say it is possible. You know, we are in a urban city. We see a lot of patients with various insurance status and access to technologies, and we've had a very high show rate in our post-hospital transitional program, so it can be done with a thought and, uh, care to those vulnerable populations who may need more attention across the transition.  Dr Grouse: Well, I really appreciate all the work you've done in this area, and it sounds like it's an area that will continue to grow as we learn more and hopefully improve. And I really appreciate you taking the time out of your day to talk with us about your article.  Dr Bahouth: Well, thank you for having me, and it's a topic that's near and dear to us, so thanks again for highlighting its importance.  Dr Grouse: Again, today I've been interviewing Dr. Mona Bahouth about her article on transitional stroke care and the road to recovery. This article appears in the June 2026 Continuum issue on cerebrovascular disease. Be sure to check out Continuum Audio episodes from this and other issues, and thank you to our listeners for joining today.  Dr Monteith: This is Dr. Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

Concerned about plastics in the environment? In you? Today is the story of how two scientists embarked on a journey to bind plastics so our body excretes them instead of absorbing them. Drs. Nicholas Monsul (Yale University & The Johns Hopkins Hospital) and Dr Eva Berkes (Scripts Inst.) are physician-scientists and co-founders of Quorum Innovations, a biotechnology company working with bacteria to achieve extraordinary results. They have an innovative biofilm, postbiotic technology that binds 98% microplastics in the digestive tract with human trial results now live and a recently published paper.This is the first publication to demonstrate a technology capable of binding plastics to a bacterium in the digestive tract, in humans. The paper is currently under review in the Journal “Frontiers of Microbiology”. Very exciting stuff and I can't wait for you to dive into the show. Alexx StuartYour Hosthttps://www.biorxiv.org/content/10.64898/2026.05.11.724280v1 Want to learn more about this week's guest? Website: quourminnovations.com and Qi601.com Instagram: https://www.instagram.com/qi601_ Facebook: https://www.facebook.com/Qi601 Thank you to this month's show partners for joining us to help you make your low tox swaps! @waterscofilters helps you take all the contaminants out + keep all the deeply hydrating minerals IN with 7-15 stages of filtration, depending on which water filter you choose. Head to waterscoaustralia.com.au > 15% off when you tick subscription on any new filter until 30th of June. That's 15% off the new filter + refills thereafter for the life of the subscription to the replacements.@ausclimate is our major partner giving you 10% off their range for the whole of 2025, with brilliant Winix Air Purifiers, the best Dehumidifiers I've ever used and their new energy-efficient heating, air-circulating and cooling range. code LOWTOXLIFE (also works over and above their sales - pro tip!) https://bit.ly/ShopAusclimateBe sure to join me on Instagram @lowtoxlife and tag me with your shares and AHAs if something resonated! I love to see your thoughts, genuinely! Want to support the Low Tox Life podcast? Free option: Leave a 5 star review wherever you listen to Low Tox Life - thanks SO much! Paid + Member PERKS: Join the Low Tox Club - monthly practitioner live masterclasses, a suite of low tox store discounts from around the world and the most supportive and lovely chat group on all low tox topics on the internet: Check it out and join here for just the price of a coffee per month! Hosted on Acast. See acast.com/privacy for more information.

"You shouldn't be spending more than five minutes in there at a time,” says Trisha Pasricha, MD, MPH. A graduate of Harvard College, Pasricha earned her medical degree from Vanderbilt University School of Medicine and a Master of Public Health from the Harvard T.H. Chan School of Public Health. Her training includes an internal medicine residency at The Johns Hopkins Hospital and gastroenterology and motility fellowships at Massachusetts General Hospital. Currently, Pasricha is an assistant professor of medicine at Harvard Medical School and director of the Institute for Gut-Brain Research at Beth Israel Deaconess Medical Center, an NIH-funded research laboratory at the forefront of gut-brain science. Her book, You've Been Pooping All Wrong, is out now.  00:00 - What actually makes a bowel movement healthy 07:55 - The Bristol Stool Chart explained 10:50 - The case for bidets 14:49 - What hemorrhoids actually are 17:44 - The smartphone-hemorrhoid study 20:33 - Fiber timing & psyllium husk 24:03 - The rise in early-onset colorectal cancer 27:43 - Microbiome testing 30:03 - The future of gut health 32:33 - Why we can't poop when traveling 35:40 - How much gas is actually normal 38:01 - Runners with the runs 41:10 - How to overhaul your gut in 30 days Referenced in the episode:  For more about Pasricha, visit her website: https://www.trishapasricha.com/  Buy Pasricha's book here: https://a.co/d/0gZZImBR  Smartphone usage on the toilet study: https://pmc.ncbi.nlm.nih.gov/articles/PMC12407481/ We hope you enjoy this episode, and feel free to watch the full video on YouTube! Whether it's an article or podcast, we want to know what we can do to help here at mindbodygreen. Let us know at: podcast@mindbodygreen.com. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of Transmission Interrupted, host Jill Morgan sits down with Dr. Gaby Frank, internist and director of the Special Pathogens Center at Johns Hopkins, to provide clarity and insight on the current hantavirus outbreak. The conversation kicks off by demystifying essential public health terms like "isolation" and "quarantine," explaining their definitions and uses in the context of infectious diseases in the U.S. Jill and Dr. Frank then dive into the science behind hantavirus, specifically the unique Andes virus strain in Argentina and its rare but notable potential for human-to-human transmission, a distinction setting it apart from the many other hantavirus strains found throughout the Americas. Listeners will gain a clearer understanding of how hantavirus is typically contracted—primarily from aerosolized rodent droppings rather than person-to-person transmission—and the actual risks associated with exposure. The episode highlights findings from a long-term study in Chile, which revealed only 3.3% of close contacts developed the disease, with greatest risk among household and romantic partners. Jill and Dr. Frank dispel some of the fear and misinformation circulating about hantavirus, stressing that while severe cases can occur, the general public's risk remains very low. Through expert perspective and practical advice, this episode underscores the importance of strategic preparedness and ongoing research, empowering listeners with the knowledge they need to stay safe and informed. Guest Maria (Gaby) Frank, MD, FACP, SFHM Professor of Medicine, PAR, Johns Hopkins University Director, Johns Hopkins Special Pathogens Center Dr. Frank is a hospitalist. Professor of Medicine PAR, and the Director of Johns Hopkins' Special Pathogens Center Johns Hopkins Hospital in Baltimore, MD, one of the 13 Regional Emerging Special Pathogen Treatment Centers (RESPTCs). The Johns Hopkins Hospital (JHH) is a premier 1000-bed non-profit academic medical center within the larger Johns Hopkins Health System, one of the leading health care systems in the United States. The 5-hospital health system in the Baltimore-Washington area has 2513 beds (354 intensive care unit beds) and serves approximately 7 million people. JHH provides a full range of clinical services including specialty care for both adults and pediatric patients. The Johns Hopkins Hospital was ranked number one in the nation by U.S. News & World Report for 22 years of the survey's 30-year history. Before joining Johns Hopkins, Dr. Frank was the Medical Director of the biocontainment unit at Denver Health and Hospital Authority. In her role as the medical director of BCU, she served as the site Principal Investigator for the NIH-sponsored ACTT trial and is actively involved in the National Emerging Special Pathogen Training and Education Center (NETEC) and Special Pathogens Research Network (SPRN). Dr. Frank received her medical diploma from the University of Buenos Aires in Buenos Aires, Argentina, and completed a residency in Internal Medicine and another in Emergency Medicine in Argentina. She immigrated to the U.S. in 2004, where she completed another Internal Medicine Residency at the University of Colorado, joining as faculty after graduation. Her areas of interest include emergent special pathogens, and disaster preparedness and response. Host Jill Morgan, RN Emory Healthcare, Atlanta, GA Jill Morgan is a registered nurse and a subject matter expert in personal protective equipment (PPE) for NETEC. For 35 years, Jill has been an emergency department and critical care nurse, and now splits her time between education for NETEC and clinical research, most of it centering around infection prevention and personal protective equipment. She is a member of the Association for Professionals in Infection Control and Epidemiology (APIC), ASTM International, and the Association for the Advancement of Medical Instrumentation (AAMI). Resources From Mice to Medicine: Exploring Hantavirus and Protecting Healthcare TeamsNETEC Hantavirus InformationSBAR: Andes HantavirusNETEC Webinar Hantavirus Town Hall: Updates for Frontline StaffTransmission Interrupted PodcastNETEC Resource Library About NETEC A Partnership for Preparedness The National Emerging Special Pathogens Training and Education Center's mission is to set the gold standard for special pathogen preparedness and response across health systems in the U.S. with the goals of driving best practices, closing knowledge gaps, and developing innovative resources. Our vision is a sustainable infrastructure and culture of readiness for managing suspected and confirmed special pathogen incidents across the United States public health and health care delivery systems. For more information visit NETEC on the web at www.netec.org. NETEC Consultation Services Assess and Advance Your Readiness for Special Pathogens with Free, Expert Consulting. NETEC offers free virtual and onsite readiness consulting to help health care facilities and EMS agencies prepare for special pathogen events. Our targeted support services are delivered by experts selected and assigned to each inquiry based on the unique needs of your organization. Have a question? Ask a NETEC expert. For more information visit: netec.org/consulting-services.

When it comes to exploring senior roles in academic medicine and understanding how one goes about achieving them, we have the perfect guest this week on the Faculty Factory Podcast as we welcome Jenny Mladenovic, MD, MBA, MACP. She joins us to help make sense of the opportunities available and to shed light on the variables to consider when pursuing one. "I do think it's really important to recognize that faculty have chapters in their life and they may not be interested now, or there may not be opportunity now, but it is still important to understand what these roles are, what they mean, and why we have them," she said. She also reminds us that if you ever think you are overreaching for a job, you have nothing to lose by applying, except perhaps your pride. "The reality is that there is no perfect job and you will never know everything going into a job. Once you start with that, it makes it a little easier," she said. In leadership, communication skills are essential, as are operational expertise, discipline, and at least some level of financial management. The good news is that all of these skills can be developed. "I have my personal biases, so everything I say should be filtered through that. But I believe a dean's role is most important in recruiting and managing faculty. They have to have some mix of charisma and operational expertise," she said. About Dr. Mladenovic Dr. Jenny Mladenovic is President and CEO of the Center for Women in Academic Medicine and Science (CWAMS) and Chair/Founder of the GEMS Alliance. Previously she was Executive Vice-President and Provost at Oregon Health Sciences University (OHSU) and has held positions as senior associate dean at two institutions. Additionally, Dr. Mladenovic is an AOA graduate of the University of Washington and trained at Johns Hopkins Hospital, Stanford University, and the University of Washington.  For nearly two decades, she had an NIH/VA funded laboratory focused on hematopoietic cell differentiation. She holds an MBA from the University of Miami and is a certified mediator.

In this episode of Dismantling You, I sit down with Dr. Jennifer Kulp-Makarov, a Board-Certified Reproductive Endocrinologist and founder of Fleura Fertility, trained at Johns Hopkins and Yale. We dig into how traditional fertility clinics often rely on a one size fits all approach to IVF, and why that can actually backfire for women with low AMH or those trying to conceive over 40. Dr. Jennifer shares the patient experience that changed everything for her: a woman who gave up on growing her family because she thought aggressive, high dose IVF was her only option. That moment became the catalyst for her to build a practice centered on personalized protocols and her signature Goldilocks approach to stimulation, finding the just right dose of medication rather than defaulting to the highest one.We also explore cutting edge fertility innovations including ovarian PRP, which is showing promise in improving markers like AMH and antifollicle count, and rapamycin, an emerging treatment that may help protect egg reserves and delay menopause. Dr. Jennifer breaks down how FSH dosing plays a critical role in egg competence and why monitoring it throughout the cycle, not just at baseline, makes a real difference. We talk about how fertility care is evolving to better support LGBTQ individuals through inclusive language and treatment design, and how AI could soon help standardize ultrasound data and embryo analysis. We wrap up with Dr. Jennifer's rapid fire answers on the most underrated factor in fertility, the biggest mistake patients make when choosing a clinic, and the one belief she had to dismantle in her own career.__________________________________________________Key Highlights

For the past 150 years, the power players in Washington D.C. have been using Johns Hopkins University to outsource their dangerous research and development projects. The School of Medicine and the Johns Hopkins Hospital have been in operation for over a century, and their connections to Big Pharma, the World Health Organization, and the military are well documented.The Center For Health Security has been running bioterrorism drills for the past two decades simulating influenza pandemics, aerosolized smallpox, and powdered anthrax attacks. Best known for Event 201 in October of 2019, their ability to predict the future is alarming and screams “advanced knowledge”.—Video ChannelsWatch the video version of Macroaggressions:Rumble: https://rumble.com/c/Macroaggressions YouTube: https://www.youtube.com/@MacroaggressionsPodcastBrighteon: https://www.brighteon.com/channels/macroaggressions/—MACRO & Charlie Robinson LinksHypocrazy Audiobook: https://amzn.to/4aogwmsThe Octopus of Global Control Audiobook: https://amzn.to/3xu0rMmWebsite: www.Macroaggressions.ioMerch Store: https://macroaggressions.dashery.com/ Link Tree: https://linktr.ee/macroaggressionspodcast—Activist Post FamilySign up for the Activist Post Newsletter: https://activistpost.kit.com/emailsActivist Post: www.ActivistPost.comNatural Blaze: www.NaturalBlaze.com —Support Our SponsorsGround Luxe Grounding Mats: https://GroundLuxe.com/MACROReplace Your Mortgage: www.WipeOutYourMortgageNow.comC60 Power: https://go.ShopC60.com/PBGRT/KMKS9/ | Promo Code: MACROChemical Free Body: https://ChemicalFreeBody.com/macro/ | Promo Code: MACROWise Wolf Gold & Silver: https://Macroaggressions.Gold/ | (800) 426-1836LegalShield: www.DontGetPushedAround.comEMP Shield: www.EMPShield.com | Promo Code: MACROChristian Yordanov's Health Program: www.LiveLongerFormula.com/macroAbove Phone: https://AbovePhone.com/macro/Van Man: https://VanMan.shop/?ref=MACRO | Promo Code: MACROThe Dollar Vigilante: https://DollarVigilante.spiffy.co/a/O3wCWenlXN/4471Nesa's Hemp: www.NesasHemp.com | Promo Code: MACROAugason Farms: https://AugasonFarms.com/MACRO—

Resources: Abstract: Pressure Injury Prevention in the Oncology Population ePoster: Pressure Injury Prevention in the Oncology Population Wound Treatment Associate (WTA®) Program Journal of Wound, Ostomy, and Continence Nursing (JWOCN®)   About the Speaker: Dr. Lisa Marie Grubb is a wound, ostomy, and continence nurse and nursing leader at Johns Hopkins Hospital, where she focuses on improving skin and wound outcomes for complex patient populations. Her work centers on pressure injury prevention, where treatment-related skin changes, immobility, nutrition challenges, and device use can quickly increase risk. With decades of nursing experience and a strong background in quality improvement and clinical education, she partners with bedside teams to translate evidence into practical prevention strategies that fit real-world workflows.  Editing and post-production work for this episode was provided by The Podcast Consultant.

For many of us, our instinctual response to rising conflict and instability might be to recede further into pragmatism as a way to survive. Yet, if our cultural values and ways of life are what got us here, rooted in narrow-boundary, cold, and logical thinking – then perhaps moments of turbulence like these actually call on us to change our way of thinking entirely. Is this moment our opportunity to pivot toward worldviews that emphasize the intangible qualities of life, and could that shift cause a cascade through our actions and decisions, leading to more balanced decision-making for the betterment of everyone?  In this episode, Nate is rejoined by philosopher and neuroscientist Iain McGilchrist for discussion on how our left-brain dominance obscures our sense of value, especially for abstract qualities such as truth, goodness, and beauty. As a way to reclaim an appreciation for these things, he urges us to slow down, create spaciousness, embrace silence and deep listening, and resist the mania for productivity in our modern culture. Nate and Iain also discuss consciousness, panpsychism, and panentheism, exploring the thread that there might be some form of universal current running through everything, uniting us all. Bringing everything together, Iain calls for a recovery of humility, compassion, awe, and wonder and insists that even a small percentage of people genuinely living differently could begin to shift cultural consciousness.  How do the things we choose to pay attention to affect our ability to see what's important in the world – and subsequently what we value and prioritize? What would it feel like to treat each day as a gift rather than a problem to solve, and how might that shift our relationship with time, mortality, and meaning? Most of all, is it possible for some subset of humans to reground ourselves and our behavior in the interconnectedness of life, and could those small changes add up to meaningfully alter humanity's current trajectory?  (Conversation recorded on March 24th, 2026)   About Iain McGilchrist:  Dr. Iain McGilchrist is a Quondam Fellow of All Souls College, Oxford, an Associate Fellow of Green Templeton College, Oxford, a Fellow of the Royal College of Psychiatrists, a Fellow of the Royal Society of Arts, and former Consultant Psychiatrist and Clinical Director at the Bethlem Royal & Maudsley Hospital, London.  Iain has been a Research Fellow in neuroimaging at Johns Hopkins Hospital, Baltimore and a Fellow of the Institute of Advanced Studies in Stellenbosch. He has published original articles and research papers in a wide range of publications on topics in literature, philosophy, medicine and psychiatry.  Iain is the author of a number of books, but is best-known for The Master and his Emissary: The Divided Brain and the Making of the Western World (2009); and his book on neuroscience, epistemology, and ontology called The Matter with Things: Our Brains, Our Delusions and the Unmaking of the World (2021).   Show Notes and More   Watch this video episode on YouTube   Want to learn the broad overview of The Great Simplification in 30 minutes? Watch our Animated Movie.   ---   Support The Institute for the Study of Energy and Our Future   Join our Substack newsletter   Join our Hylo channel and connect with other listeners

We welcome back Meredith Mangold to shift the conversation from the medical "odyssey" to the human connection. While the first part of Meredith's story (Episode 76) focused on her grueling search for a diagnosis and treatment for ulcerative colitis, POTS, and EDS, in this episode, we explore the essential, and often overlooked, role of support systems. Living with chronic pain at an "8 out of 10" for years isn't just a physical challenge; it's a relational one. Meredith joins hosts Cathy and Beth to discuss what it means to be truly supported when an illness doesn't have an end date. We dive into the nuances of communication, the "guilt of being too much," and the common mistakes well-meaning loved ones make when trying to "fix" a situation that can't be fixed. Whether you are navigating a chronic condition yourself or walking alongside someone who is, this episode offers a masterclass in empathy, validation, and the power of simply being believed.   Episode Topics: Survival vs. Support: Identifying the moments when external support became essential to Meredith's survival during her hardest years of chronic pain. The Anatomy of a Support System: What effective support looks like practically, emotionally, and through "quiet presence." Validation vs. "Fixing": Why well-meaning advice can sometimes feel harmful and how to pivot toward validation and safety. The Burden of Guilt: Navigating the fear of being "too much" for friends and family. Communicating the Invisible: Tips for articulating needs when pain is invisible and chronic. Advocacy without Burnout: How patients can ask for what they need without feeling ashamed. About the Guest: Meredith Mangold, CPXP, is the Founder of Empower Health Strategies and a Certified Patient Experience Professional. After being thrust into the healthcare system at age 20 with severe ulcerative colitis, later followed by diagnoses of POTS and Ehlers-Danlos Syndrome, Meredith dedicated her career to helping healthcare professionals and digital health innovators empathize with the patient journey. She serves on the board of the Chronic Pain Project, is a faculty member for the BiteLabs Fellowship, and collaborates with Johns Hopkins Hospital on patient advocacy initiatives. Resources & Links Mentioned: Meredith's Website: Empower Health Strategies Connect on LinkedIn: Meredith Mangold The Chronic Pain Project: chronicpainproject.org Read Meredith's Story: Emerging from the Fog (Johns Hopkins Medicine) The Chronic Illness Hotline: A text-based peer support line for those navigating chronic illness, pain, and disability. Support their mission or find help at chronicillnesshotline.org. Relevant It Happened To Me Podcast Episodes: #17 Mental Health Help with Social Worker Tamara Blum #25 Pancreatic Cancer with Patient Advocate Leslie Waldman #38 Dr. Tara Zier on Stiff Person Syndrome #66 Not Just Fatigue: Global Advocating for ME/CFS from Bed  #76 When Pain Never Stops: A Survivor's Story of Chronic Pain and Hope (Merdith's First Interview) #77 When Chronic Illness Changes the Tune: A Musician's Journey Through Diabetes and Stroke   Connect With Us:  Stay tuned for the next new episode of “It Happened To Me”! In the meantime, you can listen to our previous episodes on Apple Podcasts, Spotify, streaming on the website, or any other podcast player by searching, “It Happened To Me”.    “It Happened To Me” is created and hosted by Cathy Gildenhorn and Beth Glassman. DNA Today's Kira Dineen is our executive producer and marketing lead. Amanda Andreoli is our associate producer. Ashlyn Enokian is our graphic designer.   See what else we are up to on Twitter, Instagram, Facebook, YouTube and our website, ItHappenedToMePod.com. Questions/inquiries can be sent to ItHappenedToMePod@gmail.com. 

Episode 324: In this episode of the Medic2Medic Podcast, Steve sits down with Dr. Ashlyn Sanders, pediatric neurology resident at Johns Hopkins Hospital and Founder and Chief Medical Officer of NeuroVice.Dr. Sanders shares her personal journey following her diagnosis with Chiari Malformation, which required emergency brain surgery and led to her experiencing seizures herself. That experience fueled her mission to improve seizure care and address a long-standing gap in patient safety.The conversation focuses on the development of the PATI (Patient Airway and Tongue Injury Prevention) device, the first FDA-cleared seizure oral protection device designed to reduce oral injuries that occur in nearly one in five seizure patients. Steve and Dr. Sanders discuss challenging traditional teaching, advancing evidence-based care, and how innovation can improve outcomes for patients and providers alike. This episode highlights the intersection of personal experience, clinical insight, and innovation aimed at changing the standard of care in seizure management.Subscribe to Medic2Medic wherever you get your podcasts and share this episode with someone interested in advancing patient-centered innovation in EMS and healthcare.https://www.spreaker.com/episode/episode-324-dr-ashlyn-sanders--71085446

Conversations about brain health have been dominated by a competing mix of fatalism and over-promising, with aging framed as inevitable decline and "brain optimisation" sold through weak evidence. So how should we think about cognition across the lifespan? In this episode, we explore the idea that neuroplasticity does not disappear in adulthood, but instead continues to respond, for better or worse, to repeated behaviours and exposures. Much of what is labelled age-related cognitive decline may in fact reflect an accumulation of modifiable risk factors. We also dig into how to critically evaluate brain-health claims and how lifestyle pillars such as exercise, sleep, diet, stress reduction and cognitive training fit into a coherent framework. The discussion extends to emerging multimodal intervention programs, their promising signals and their clear limitations, and to a broader, multifactorial view of Alzheimer's disease that moves beyond a narrow amyloid-centric model. Finally, we examine the role of genetics, including ApoE4, and why genetic risk does not equate to biological destiny, even later in life. Dr. Majid Fotuhi is a neurologist and an adjunct professor at the Johns Hopkins Mind/Brain Institute. He earned his medical degree from Harvard Medical School and completed a Ph.D. in neuroscience at Johns Hopkins University. That was followed by internship and neurology residency at Johns Hopkins Hospital. Timestamps [03:41] Understanding neuroplasticity [05:22] Risk factors for cognitive decline [07:07] Evidence-based interventions for brain health [09:37] The five pillars of brain health [10:42] Dr. Fotuhi's multimodal program [19:09] Measuring cognitive function [24:43] The role of amyloid and tau in Alzheimer's [27:53] Genetics and lifestyle in brain health [30:03] Debunking myths and overhyped claims [36:08] Key ideas segment (premium subscribers only) Related Resources Go to episode page (with links to studies mentioned) Join the Sigma email newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course Dr. Fotuhi's book: The Invincible Brain

One of the most corrosive elements in the human character is unforgiveness. Bitterness and fighting in relationships is really a drain. Physically and emotionally, we're simply not wired to survive long-term problems in this area. According to Dr. Michael Berry, 61% of cancer patients have forgiveness issues. And Dr. Karen Schwartz of the Johns Hopkins Hospital confirms that the hurt and disappointment associated with forgiveness issues can spike incidents of heart disease, depression, and diabetes. On the other hand, forgiveness calms stress levels, leading to improved health. The Bible tells us that we can make the decision to forgive when someone wrongs us. In Colossians 3:13, we read, “Make allowance for each other's faults, and forgive anyone who offends you. Remember the Lord forgave you so you must forgive others.” Did you notice that? We should basically cut each other some slack. We all fail, but making a choice to let it go, especially with an individual, will benefit everyone. Your own stress will melt away. It's like a gift you can give yourself. In a Focus on the Family article by Rose Sweet, we find this key piece of wisdom that can unlock our inability to forgive: “Forgiveness is returning to God the right to take care of justice. By refusing to transfer the right to exact punishment or revenge, we are telling God we don't trust him to take care of those matters.” So, you see, it's not really so much about the person who wronged you, it's more about your refusal to let God handle it. By doing that, by letting God handle it, taking that critical step, we can step into the freedom that God had waiting for us the whole time. Your physical health will improve, but that pales in comparison to the improvement in your spiritual health. Let's pray. God, an unforgiving spirit is so hard to carry. Help us see daily that we can choose to forgive just like you chose to forgive us. In Jesus' name, amen. Change your shirt, and you can change the world! Save 15% Off your entire purchase of faith-based apparel + gifts at Kerusso.com with code KDD15.

Henrietta Lacks is the woman behind one of the most important medical breakthroughs in modern history. In 1951, a young Black mother of five sought treatment for cervical cancer at Johns Hopkins Hospital. Without her knowledge or consent, doctors took samples of her cancer cells. Those cells—later known as HeLa cells—became the first human cells to survive and reproduce indefinitely in a lab. They went on to revolutionize science, contributing to the development of the polio vaccine, cancer treatments, IVF, gene mapping, and countless medical advancements that have saved millions of lives. But while Henrietta's cells changed the world, her family remained in the dark for decades—unaware that a part of her was still alive in laboratories across the globe. This episode examines not only Henrietta's life and legacy, but the complex ethical questions her story raises about consent, race, medical exploitation, and who benefits from scientific progress. Follow us on IG: @homance_chronicles Connect with us: linktr.ee/homance Send us a Hoe of History request: homancepodcast@gmail.com

Send us a textFebruary is National Heart Month, and in the month of hearts, we're revisiting one of the most important conversations from the Ageless Glamour Girls™ Podcast archives.Broken Heart Syndrome can mimic the symptoms of a heart attack - and it can occur after sudden, intense emotional or physical stress. Research shows cases are increasing, particularly among middle-aged and older women. This episode originally aired during our debut season in March 2022, but its message feels even more urgent today. We're joined by Dr. Susan Cheng, senior author of a major study on the condition and a leading cardiologist at the Smidt Heart Institute at Cedars-Sinai. Dr. Cheng breaks down:What Broken Heart Syndrome is - and what it isn'tWhy women are disproportionately affectedThe powerful role stress plays in heart healthAnd, most importantly, why this condition is treatableIf you've ever felt the physical weight of emotional stress, this conversation matters. And here's to Healthy Aging and Joyful Living, Luvvies!**********************GUEST BIO: Susan Cheng, MD, MMSc, MPH is the Erika J. Glazer Chair in Cardiovascular Health and Population Science, Director of the Institute for Research on Healthy Aging, and Director of Population Health Sciences at the Smidt Heart Institute at Cedars-Sinai. She also serves as Professor and Vice Chair of Research Affairs in the Department of Cardiology. Dr. Cheng is a cardiologist, echocardiographer, and clinician-scientist who leads nationally recognized research programs focused on the drivers of cardiovascular aging in women and men. She received her bachelor's degree from Harvard College, her medical degree from McMaster University, a Master of Medical Science from MIT, and a Master of Public Health from Harvard.She completed internal medicine training at The Johns Hopkins Hospital and cardiology training at Brigham and Women's Hospital and Harvard Medical School, where she later served as cardiology faculty and Associate Director of the Cardiovascular Imaging Core Laboratory. Dr. Cheng is also Co-Director of the Framingham Heart Study Echocardiography Laboratory and Co-Director of the international Bioactive LipidsNet Consortium. She has served on editorial boards of major cardiovascular and imaging journals and on leadership committees for the American Heart Association and the American College of Cardiology. Dr. Cheng has chaired and contributed to multiple American Heart Association scientific statements on research methods, heart disease statistics, and cardiovascular care of older adults. She has authored more than 4Support the show https://buymeacoffee.com/agelessglamourgirls www.linkedin.com/in/marqueetacurtishaynes www.agelessglamourgirls.com https://www.shopltk.com/explore/AgelessGlamourGirls https://www.youtube.com/@agelessglamourgirls Instagram @agelessglamourgirls Facebook: https://www.facebook.com/agelessglamourgirls Private (AGG) FB Group: The Ageless Café: https://www.facebook.com/groups/theagelesscafe TikTok: @agelessglamourgirls Podcast Producers: Ageless Glamour Girls and Purple Tulip Media, LLC

Most medical encounters are structured as transactions. The patient comes in with a specific complaint, the medical expert identifies a discrete problem, and a specific intervention is prescribed.But at the heart of a medical encounter is a story. When a patient comes in with a medical problem, the problem cannot be disentangled from their life's narrative — doing so risks hollowing out the essence of what it means to care for another person. Our guest on this episode is award-winning author, and primary care physician Suzanne Koven, MD. Following the completion of her residency at Johns Hopkins Hospital, Dr. Koven joined the faculty at Harvard Medical School and practiced primary care medicine at Massachusetts General for 32 years. In 2019, she became the inaugural Writer in Residence at Mass General. Her writings have been published broadly—including in The Boston Globe, The New England Journal of Medicine, The Lancet, and The New Yorker. As a teacher and public speaker, she highlights the relationship between literature and medicine, and is a powerful advocate for female medical trainees. In this episode, Dr. Koven shares her journey to medicine at a time when few women were represented in the field and why she finds her undergraduate English classes to be more relevant to her clinical work than her science classes. We discuss narrative medicine, its value to patients and physicians alike, and how the modern healthcare system struggles to value the patient story. Finally, Dr. Koven leaves us with her advice for up-and-coming trainees: find a place in medicine where you can be yourself – for your own good and for your patients'.In this episode, you'll hear about: 3:00 - Dr. Koven's motivations for going into primary care medicine 15:49 - The impact that Dr. Koven's English degree has had on her approach to medicine 19:36 - What narrative medicine is 24:34 - What is lost when human connection and human story are deprioritized within the practice of medicine 31:15 - The benefits doctors experience when cultivating an appreciation for the arts37:21 - How gender representation in medicine has shaped Dr. Koven's experience as a physician42:54 - The need for the culture of medicine to adapt to changing demographics in the medical workforceIf you enjoyed this episode, please subscribe, rate, and review our show, available for free on Spotify, Apple Podcasts, or wherever you get your podcasts. If you know of a doctor, patient, or anyone working in health care who would love to explore meaning in medicine with us on the show, feel free to leave a suggestion in the comments or send an email to info@thedoctorsart.com.Copyright The Doctor's Art Podcast 2026

Happy New Year listeners! We hope you enjoyed the holidays and are off to a wonderful start of 2026!    The last episode we released featured our Executive Producer Kira Dineen putting on her genetic counseling hat to explore how genetic counselors can help those in the rare disease community. With how much you all enjoyed that “blast from the past” episode, we thought we would bring you one more before our new episodes of 2026 kick off.  So we are continuing on the topic of rare diseases genetics, and revisiting our episode with Amy Patterson, who is a genetic counselor as well. In this conversation she shares with Cathy and Beth about genetic screening and testing available for rare diseases including her speciality of skeletal dysplasia.   Genetic Counselor Amy Patterson shares about genetic screening and testing available for rare disease including her speciality of skeletal dysplasias.    Amy Patterson (she/her) is a licensed pediatric and adult genetic counselor in the Johns Hopkins Department of Genetic Medicine. She primarily works with patients in the Greenberg Center for Skeletal Dysplasias as well as the General Genetics clinic. Especially in the skeletal dysplasia space, Amy works to promote a holistic patient experience, including psychosocial counseling, connection with patient advocacy groups, informed consent, genetic testing and interpretation of results, coordination of care, and discussion of research options. Amy was a LEND Fellow and graduated from the Boston University Genetic Counseling program in 2021. She has focused much of her research and clinical work on the intersection of rare conditions, disability, and patient advocacy.   Amy initially started advocating in the rare disease space due to her best friend's sibling's rare genetic disorder, Congenital Hyperinsulinism. We actually interview their mother on Episode 37 of It Happened To Me. As a high schooler, Amy started educating their peers and community about rare disease on Rare Disease Day every year. After moving to Boston, she started volunteering at a Community Engagement Liaison for the Rare Action Network (RAN), the advocacy branch of NORD, then became the RAN Massachusetts State Ambassador. Through this work, she started putting on Rare Disease Day events at Boston Children's Hospital, and now at Johns Hopkins Hospital as a genetic counselor. Rare Disease Day allows all rare disease stakeholders to come together to share their experiences and continue to learn. Amy is passionate about this global effort to raise awareness and advocate for improved quality of life, diagnosis, and access to care for Rare patients and families.   Want to listen to our other episodes with genetic counselors?    In Episode 4, our Executive Producer, Kira Dineen, who is also a genetic counselor, shares how genetic counselors can help people navigate having a rare disease.    In Episode 7, Genetic Counselor Karen Grinzaid explains prenatal and cancer genetic testing. Kira also joins as a guest host since this is her area of expertise.    Want to speak to a genetic counselor? Find one in your area via FindAGeneticCounselor.org.     Stay tuned for the next new episode of “It Happened To Me”! In the meantime, you can listen to our previous episodes on Apple Podcasts, Spotify, streaming on the website, or any other podcast player by searching, “It Happened To Me”.    “It Happened To Me” is created and hosted by Cathy Gildenhorn and Beth Glassman. DNA Today's Kira Dineen is our executive producer and marketing lead. Amanda Andreoli is our associate producer. Ashlyn Enokian is our graphic designer.   See what else we are up to on Twitter, Instagram, Facebook, YouTube and our website, ItHappenedToMePod.com. Questions/inquiries can be sent to ItHappenedToMePod@gmail.com.   

The 2025 year draws to a close with the December episode of RAPM Focus, where RAPM Social Media Editor Alopi Patel, MD, converses with Benjamin S. Brooke, MD, PhD, and Michael “Jay” Buys, MD, following the April 2024 publication of their original research paper, “Postsurgical opioid prescribing among veterans using community care for orthopedic surgery at non-VA hospitals compared to a VA hospital with a transitional pain service: a retrospective cohort study | Regional Anesthesia & Pain Medicine.” The research study looked at opioid prescriptions after orthopedic surgery for veterans, comparing veterans who underwent surgery at the Salt Lake City VA Hospital to those in the community. Dr. Brooke is a Professor of Surgery, Biomedical Informatics (adjunct), Population Health Sciences (adjunct), and Chief of the Division of Vascular Surgery at the University of Utah. He grew up in Salt Lake City, receiving his Doctor of Medicine from the University of Utah before heading east to complete his internship and residency in General Surgery at the Johns Hopkins Hospital. During his surgical residency, Dr. Brooke received his PhD in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health. He then completed a fellowship in Vascular Surgery at the Dartmouth-Hitchcock Medical Center. Dr. Buys is an Associate Professor (Clinical) of Anesthesiology at the University of Utah and Chief of the Acute/Transitional Pain Section at the Salt Lake City VA Medical Center. He completed his medical degree at the University of Iowa and residency in anesthesiology at the University of New Mexico, after which he served as an active duty anesthesiologist in the US Air Force at Wilford Hall Medical Center in San Antonio and at Craig Joint Theater Hospital in Afghanistan. *The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice, and it is not intended to function as a substitute for a healthcare practitioner's judgement, patient care, or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others. Podcast and music produced by Dan Langa. Find us on X @RAPMOnline, LinkedIn @Regional Anesthesia & Pain Medicine, Facebook @Regional Anesthesia & Pain Medicine, and Instagram @RAPM_Online.

Dr. Rob Bradsher is the Medical Director for the TeamHealth Hospitalist program at Baptist Memphis. He is from Arkansas and went to medical school at UAMS where he was inducted into Alpha Omega Alpha. He has practiced in Memphis as a hospitalist since 2014 after completing his residency training in the Osler program at Johns Hopkins Hospital. He has built a distinguished career in both academic medicine and clinical practice, serving as Program Director for a large Internal Medicine residency at the University of Tennessee Health Science Center for many years before transitioning into hospital leadership. Dr. Bradsher has been recognized with numerous teaching and leadership awards, including UTHSC's inaugural Program Director of the Year. Beyond healthcare, Dr. Bradsher is an unabashed family man, married to Allison and a proud father of 4 kids. He serves on the Board of Directors of the kids' school, Westminster Academy. He also loves tennis - as an avid recreational player, "tennis dad", and a big fan of the professional tours.With more than two decades in nursing and 16 years in leadership, Jodi Woods, MSN, RN, has dedicated her career to shaping both patient care and the growth of future leaders. Currently serving as Associate Chief Nursing Officer, she has spent 13 years at Baptist Memorial Hospital in Memphis in roles of Manager and Director, where she led teams with a focus on collaboration, innovation, and accountability. Passionate about ensuring positive patient experiences and high-quality care, Jodi thrives on mentoring and empowering others to achieve their professional goals while driving excellence in healthcare delivery.Dr. Nirmit Kothari presently serving as Associate Chief Medical Officer at Baptist Memorial Hospital, Memphis, TN. Dr. Kothari is a seasoned internist and hospital medicine specialist affiliated with Baptist Memorial Hospital–Memphis, with over two decades of medical experience.Link to claim CME credit: https://www.surveymonkey.com/r/3DXCFW3CME credit is available for up to 3 years after the stated release dateContact CEOD@bmhcc.org if you have any questions about claiming credit.

In this episode of the Braun Performance & Rehab Podcast, Dan is joined by Rayce Houser & Joey Scambia to discuss considerations for athletic lower back pain. Joey is a board-certified sports clinical specialist and currently works for Johns Hopkins All Children's Hospital, treating student-athletes at IMG Academy in Bradenton, Florida.He obtained his Doctorate of Physical Therapy from the University of Rhode Island in 2021, where he had the fortunate opportunities to learn from renowned ACL experts Mike Reinold, Lenny Macrina, and Zach Baker.He completed a Sports Residency at Johns Hopkins Hospital in Maryland in 2022 where he was able to receive extensive education regarding ACL rehabilitation. Joey played Division 1 baseball at Northeastern University where a significant back injury sparked his passion for returning athletes back to their sport.Rayce is a board-certified orthopedic clinical specialist and currently works at ROKKE in Portland, Oregon. He graduated from Pacific University with his Doctorate of Physical Therapy in 2021 and then completed an orthopedic residency with the University of Maryland in 2022.Rayce served as the strength and conditioning coach for Pacific University's baseball and softball team, Eastern Oregon University's baseball team, and Southwestern Oregon Community College's baseball team over a 6 year span.​Rayce competed in 4 collegiate sports (football, baseball, golf, and swim) where a significant back injury ignited his interest for sports rehabilitation.For more on Joey, Rayce & Rehab Renaissance be sure to check out https://www.rehab-renaissance.com/ & rehabrenaissance on instagram.Season 6 and 7 of the Braun Performance & Rehab Podcast is brought to you by Pura Health - Bringing ultrasound into every clinician's hand. For more on Pura Health be sure to check out https://www.purahealth.net & @pura.health_ultrasound*SEASON 6 of the Braun Performance & Rehab Podcast is brought to you by Isophit. For more on Isophit, please check out isophit.com and @isophit -BE SURE to use coupon code BraunPR25% to save 25% on your Isophit order!**Season 6 of the Braun Performance & Rehab Podcast is also brought to you by Firefly Recovery, the official recovery provider for Braun Performance & Rehab. For more on Firefly, please check out https://www.recoveryfirefly.com/ or email jake@recoveryfirefly.com***This episode is also powered by Dr. Ray Gorman, founder of Engage Movement. Learn how to boost your income without relying on sessions. Get a free training on the blended practice model by following @raygormandpt on Instagram. DM my name “Dan” to @raygormandpt on Instagram and receive your free breakdown on the model.Episode Affiliates:MoboBoard: BRAWNBODY10 saves 10% at checkout!AliRx: DBraunRx = 20% off at checkout! https://alirx.health/MedBridge: https://www.medbridgeeducation.com/brawn-body-training or Coupon Code "BRAWN" for 40% off your annual subscription!CTM Band: https://ctm.band/collections/ctm-band coupon code "BRAWN10" = 10% off!Ice shaker affiliate link: https://www.iceshaker.com?sca_ref=1520881.zOJLysQzKeMake sure you SHARE this episode with a friend who could benefit from the information we shared!Check out everything Dan is up to by clicking here: https://linktr.ee/braun_prLiked this episode? Leave a 5-star review on your favorite podcast platform

Dr. Pedro Barata and Dr. Ravin Garg discuss strategies to increase trial representation, including leveraging trial navigators and prioritizing pragmatic trial models, as featured in the ASCO Educational Book article, "Practical Guide to Clinical Trial Accessibility: Making Trial Participation a Standard of Care." TRANSCRIPT Dr. Pedro Barata: Hello, and welcome to By the Book, a podcast from ASCO featuring compelling perspectives from authors and editors of the ASCO Educational Book. I'm Dr. Pedro Barata. I am a medical oncologist at University Hospital Seidman Cancer Center and an associate professor of medicine at Case Western Reserve University in Cleveland, Ohio. I am also the associate editor of the ASCO Educational Book. We know that in recent years, the oncology community has increasingly prioritized the need to modernize clinical trial eligibility, reduce patient burden, and enhance diversity in trial participation. On that note, today we will be speaking about ways to enhance access to clinical trials with Dr. Ravin Garg. He is a hematologist oncologist at Maryland Oncology Hematology and also an assistant professor of oncology at Johns Hopkins Hospital in Baltimore. Dr. Garg is also the co-author of a fantastic paper in the ASCO Educational Book titled, "Practical Guide to Clinical Trial Accessibility: Making Trial Participation a Standard of Care."  Dr. Garg, welcome. Thanks for being here, and congrats on your paper. Dr. Ravin Garg: Thank you for having me, Pedro. I am excited to be here. Dr. Pedro Barata: [KI1]  Your paper is a wonderful, multidisciplinary piece that actually features perspectives from the different stakeholders, right? The patient advocacy, industry, community practice, and academia about these challenges in making trials more available. This podcast is a wonderful platform. It reaches out to a lot of folks within our community. So, I will start by asking you the obvious. Why do you think it is a must read for our community, for our listeners? Dr. Ravin Garg: So Pedro, thanks again for inviting me. You do a great job with these podcasts.  So, I think first and foremost, oncologists right now are under a lot of stress, just in terms of clinical volume. There is concern for research money, and how we get the best care for our patients. So I think this article is very important because it helps bring together, as you had mentioned, the stakeholders throughout academic to community practice and everywhere in between, and try to find how, as a team with different oncologists who partake in different aspects of oncology, can come together to streamline the process to try to get our patients on trials, or certainly have them have availability of trials, just if they are interested in going on them. Being in practice, we have had several challenges that we can talk about throughout this podcast, but I think it is a very important paper because it recognizes that at the end of the day, it takes a team effort for all of us in academics, community, industry, and pharmaceuticals to really come together as a team to really help put forth the trials for our patients. Dr. Pedro Barata: So, from the perspective of a community oncologist, how do you put together, or maybe you can describe some of the challenges that you see to increase trial participation in the community? Dr. Ravin Garg: Yes, Pedro, that is a great question, and it is something that I keep on thinking about and trying to find ways to be better at it myself. But I will say some of the challenges as a community doctor that I have seen for myself and talking to other colleagues. Number one, I do think there is a lot of stress on doctors in the community in general, Pedro. Oftentimes we are tasked to see a wide smorgasbord of patients, so we may not have the luxury of being a specialist in any particular tumor subtype. Like oftentimes, we will have to see lung cancer, the next one will be breast cancer, the next one could be CML, the next one could be thrombocytopenia. And as you know better than I do, Pedro, the field in each one of these disciplines is changing so rapidly: molecular genomics, radioligand treatments, different imaging tests, MRD testing for some of our hematologic malignancies. And I think one challenge we have in community is just keeping up with the basics of Oncology 101. In the process of doing that, it can be very difficult to sometimes remember that we have very exciting trials available for our patients. So, I think a lot of it is the day in and day out of being an oncologist is so taxing at times that oftentimes a research trial is not the first thing in our head space when we see a patient. I think number two, Pedro, at least in the community, and perhaps this is with academics too, is that we are bombarded, I would say, by a lot of messaging these days. We have in-baskets to go through, labs to go through, things of that nature. And in the process of a patient visit, seeing them, doing an exam, taking a history, trying to go over the NCCN guidelines on best practice for how to manage their care, at least for me at times, it is very hard to remember, "Hey, there might be a great trial available, whether within our network or maybe partnering with an academic center." So getting through a day can be fraught with a lot of peril and just difficulties, I would say. And I would say number three, Pedro, at least as, you know, I am in a private practice where I do see a wide range of benign and malignant hematology and solid tumors, so I would not call myself a specialist. And I think the challenge with that, at least for trials, Pedro, is that when you are a specialist or perhaps you are focusing on a couple of disease subtypes, you become more of an authoritative voice in those types of tumors, and you might be more aware of the trials within your network or perhaps in proxy with an academic center that you can offer your patient. So I think when sometimes we spread ourselves too thin, it can be very hard to be a thought leader, if you will, in a particular subtype of a malignancy, let's say, and maybe not be aware of a trial that could be really well-suited for your patient. In terms of ideas that myself and colleagues have had in terms of helping mitigate against some of these, I would say, setbacks or issues in the practice for trial enrollment, some of the things we have talked about, Pedro, is, number one, is we do partner with academic centers. So we live here in Maryland. We have several really fantastic academic centers. So, you know, oftentimes, not just within our practice of Maryland Oncology Hematology, we have a lot of great trials available here too, for certain, but in addition to that, we will often times work with doctors at Georgetown, Johns Hopkins, and Maryland if they have a compelling trial that we do not have within our network. It is really of the patient's interest, Pedro, to reach out to them in a collaborative manner to see if they have a trial that might be really compelling for your patient. So I do find myself collaborating a lot with colleagues in, like talented like yourself in academics. You know, I think you do a lot of GU malignancies. So as an example, like partnering with colleagues who are GU experts and say, "Hey, we have a patient with stage IV renal cell. These are the standard options I know, but are there any trials that you might have available?" I think the other thing that has been very helpful for us is having navigators within research, Pedro. Like as an example, what has really helped the uptake of trial enrollment for our center in Annapolis is having a research navigator because often times what they can do is, a priori, Pedro, before you see the patient and you are kind of formulating a standard of care treatment plan perhaps, they might tug you on the shirt and say, "Hey, we have a great trial here through Sarah Cannon, or there might be something else out there." And being aware of that when you go into a patient's room really provides a nice arena, if you will, to go and say, "The standard of care is here, but hey, we have a trial option that might be well suited for you, maybe perhaps even better, that we can talk about, too." So having research support in the community is really a huge boon, I think, Pedro, for us to really increase our enrollment for patients onto trials. Dr. Pedro Barata: Yes, I really love that, Ravin. So, let me switch gears a bit. I would love for you to talk a little bit about patient advocacy because they do play a huge role in cancer, and they address many barriers. How do you think we should leverage the patient advocacy groups to reduce patient burden and maybe have them really leverage patient advocacies to improve representation in clinical trials? What do we think we can do more? Dr. Ravin Garg: Oh, Pedro, I think they are very critically important. As a clinical oncologist now, and I would say this is for anyone in the field of medicine, you are exactly right. I think patients are bombarded by information. There are a lot of things online, whether it be TikTok, Facebook, Google, Yahoo, and people really just have a lot of information given to them. And some of it is fact driven, and some of it is not, Pedro. And oftentimes, I do think there can be at times a mistrust with some medical personnel. I think we are in an era where we are seeing that to some degree with some attributes of medicine. And I think of it as an opportunity for education for the patient and for myself as a physician. And I think patient advocates, to your point, which was well taken, serve as a bridge to both. And what I mean is that, you know, patient advocates are wonderful. They are, I think, outstanding communicators. They almost are a neutral party, Pedro, where many patients feel that they are an independent source of information that is free of bias, if you will. They are there to provide support, emotional support, scientific support for patients so they can make an informed decision. So, in terms of our practice right now, patient advocates is something that we are evolving in that capacity, I would say, Pedro. I think now more than ever, having more people as bridges of communication with care providers along with patients is of critical importance. And I would venture a guess, and I think this has been published, where patient advocates really can help tremendously in familiarizing patients with trials and what they are all about and maybe clear up some misconceptions of what trials, what the mission of trials are. Because I do think some patients, at least I have had a few over the years, where when they hear the term trial, they almost think they are being experimented upon, when, in point of fact, they could really help advance their care. That messaging along the way for some can may be mixed up a little bit. And so I think patient advocates is a really great way to offer more information for patients with a source they find very independent and trustworthy, if you will. And it can really help expedite, and I think make a more fruitful conversation for care providers, whether academic or community, and they might be more open-minded in terms of enrolling onto a trial. Dr. Pedro Barata: Wonderful. Yes, I agree. I agree with you completely.  So let's focus a little bit now on the folks designing the studies. We usually call them the sponsors. It might be an academic sponsorship, if you will, but we can also have pharma being the sponsor of a study. The angle from an academic design, it is not necessarily the same as what happens when we have pharma. And from that angle, how do you think a more inclusive research can be promoted? Dr. Ravin Garg: Oftentimes with trials, I think keeping them simple, as simple as we can. And what I mean by that is, often times for trials, Pedro, even for care providers who are enrolling, it can be daunting when there are a lot of different things involved, particularly, let's say, for investigator sponsored, which are incredibly brilliant science, incredible, but it can be a little bit daunting for patients and even the referring physician to talk about getting translational specimens, imaging, traveling to certain centers to get scans and biopsies and even different diagnostic testing like PSMA testing for, you know, prostate cancer. And it can, I think, be very intimidating for patients in terms of what might be required of him or her to enter onto a trial. Like, "This is not what I signed up for. This is laborious. This is a full time job for me. Do I have to pay for parking to go to a city? Do I have to pay for these imaging tests? And do I have to stay in a place for my family to enroll onto a trial?" So I think keeping trials as simple as possible, but yet cull the data we need as investigators where we can really advance the care, hopefully get approval for a drug, but also learn more about the medication and how it works for our patients. So I think simplifying language for trial is very important. I know when I have gone over studies for patients, Pedro, if it is a voluminous amount of information, they can right away get very intimidated. "Like, oh my goodness, this is like a term paper for college again," you know? I am joking, but you know, keeping language simplified is very important, I think, number one. And I feel that sometimes when they are asked to do a lot of different diagnostic testing, which is very important for translational work, I 100% understand, but I do think sometimes patients can get a little bit off put, if you will, and frustrated with the whole process of doing it. The second thing for our patients, Pedro, that they have mentioned to us when we put them on trials, not just within our own site but elsewhere, is that it takes a lot of time in terms of collecting information, perhaps a washout period from their last standard of treatment prior to enrollment onto a study. Many patients, Pedro, as you know better than I do, are in maybe crisis in terms of their health and their cancer might be growing, promulgating out of control, and they worry about not being able to expeditiously start onto a treatment, onto a trial. So that can lead to a lot of frustration. And one thing that you brought up, which was outstanding for me, is the enrollment criterion for some of our patients is felt to be somewhat strict. We have had some patients who may have had a remote history of a stage I malignancy that was by all accounts in remission, you know, let's say 4 or 5 years in the past, and the risk of recurrence at this point would be incredibly low, but they may not be able to enter onto a study because of some stringent criterion put forth. And that can be a little bit frustrating. In fact, I have had one or two patients who, as an example, with kidney issues, but the GFR was about 60, like right near a cutoff that oftentimes, as you know, we use where you can get into trial or not. And you know, if they are at 58, as an example, and otherwise they are a picture of health, a great candidate for a trial that will likely advance their care, and if the entry criterion is too stringent, that might be a lost opportunity for all parties involved, all stakeholders, if you will. I do appreciate the criterion for entry onto studies cannot be too liberalized. You have to have a certain baseline, but there is a little bit of a gray area and tension, of sorts, if you will, where the patient has a comorbid illness that is a disqualifying offense, but in practicality, perhaps it shouldn't be, especially if they are motivated and there is an opportunity to really advance their care. We have run into, not often, but sometimes in the past, I should say, where patients have been very off put because we try to get them onto a study and there may have been a particular feature or attribute in their underlying care that they couldn't get onto it. So I think having a little bit more thoughtfulness, perhaps, in terms of entry criterion and practicality, if you will, I think would really help enrollment onto studies. Dr. Pedro Barata: Really well said. Is there anything else that you would like to tell our listeners before we wrap up the podcast today? Dr. Ravin Garg: I would say just macroscopically speaking, it is really an honor to be an oncologist. I think I speak for both of us. Anyone listening who is thinking about the field, it is tremendous. Just the research, the bravery of our patients, and the thoughtfulness of our scientists like Pedro and translationalists and clinical trialists is really awe inspiring. So I have really loved this field. I will say from a trial perspective, we really need to enter as many patients as we can onto trials because the science is so brilliant now, the genomic underpinnings of the tumor, we are making great strides as a team of clinicians and scientists, translationalists. So the more that we can get people onto trials and get approved drugs, it is going to help them out in the end. So I think it is such an important time for all of us to come together as a community, find the best way to help our patients out. And clinical trials have to be at the forefront of how we can continue to advance care for our patients. Dr. Pedro Barata: Yeah, no Ravin, I really agree with you. We really need to increase access to clinical studies, and actually your paper is a great step in that direction by raising awareness, bringing up solutions, and again, collaboration, collaboration, collaboration is really a multidisciplinary effort to accomplish that.  Thank you so much for sharing your fantastic thoughts and insights with us. Dr. Ravin Garg: Thank you, Pedro. I am- you do a wonderful job with these podcasts. I am really honored to meet you and to be part of this. Dr. Pedro Barata: And thank you to our listeners for your time today. I encourage you to check out Dr. Garg's article in the 2025 ASCO Educational Book. We will post a link to the paper in our show notes. And please join us again next month on By the Book for more insights on key advances and innovations that are shaping modern oncology. Thank you for your attention. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Follow today's speakers:          Dr. Pedro Barata   @PBarataMD    Dr. Ravin Garg Follow ASCO on social media:          @ASCO on X      ASCO on Bluesky     ASCO on Facebook       ASCO on LinkedIn       Disclosures:       Dr. Pedro Barata:   Stock and Other Ownership Interests: Luminate Medical   Honoraria: UroToday   Consulting or Advisory Role: Bayer, BMS, Pfizer, EMD Serono, Eisai, Caris Life Sciences, AstraZeneca, Exelixis, AVEO, Merck, Ipson, Astellas Medivation, Novartis, Dendreon   Speakers' Bureau: AstraZeneca, Merck, Caris Life Sciences, Bayer, Pfizer/Astellas   Research Funding (Inst.): Exelixis, Blue Earth, AVEO, Pfizer, Merck    Dr. Ravin Garg: Patents, Royalties, Other Intellectual Property: Creator, editor, and writer of hemeoncquestions.com  

Dr. Pria Anand joins Google to discuss her book, "The Mind Electric: A Neurologist on the Strangeness and Wonder of Our Brains." The book demonstrates the compelling paradox at the heart of neurology; that even the most peculiar symptoms can show us something universal about ourselves as humans. Dr. Anand is a neurologist at the Boston Medical Center and an Assistant Professor at the Boston University School of Medicine. She is a graduate of Yale University and Stanford Medical School, and she trained in neurology, neuro-infectious diseases, and neuroimmunology at Johns Hopkins Hospital and Massachusetts General Hospital. Watch this episode at youtube.com/TalksAtGoogle.

When we think of perimenopause, we hear about hot flashes—but what about the mood swings, anxiety, and depression no one talks about?In this episode, Sarah sits down with Reproductive Psychiatrist Dr. Lindsay Standeven to break down the mental health side of perimenopause. They talk about why women are more likely to face depression during this stage, what it means if you've struggled in pregnancy or postpartum, and—most importantly—what you can do now to protect your mental health.About Dr. Lindsay R. Standeven:Dr. Lindsay R. Standeven is a Clinical Associate Professor in the Department of Psychiatry at the University of Colorado School of Medicine and Adjunct Faculty at Johns Hopkins. After completing her residency training at Johns Hopkins Hospital, Dr. Standeven completed a two-year research and clinical fellowship specializing in reproductive psychiatry. Dr. Standeven spent the earlier part of her career on the faculty at Johns Hopkins, serving as the clinical and education director for the Johns Hopkins Reproductive Mental Health Center, where she oversaw clinical staff and taught psychiatry residents in reproductive psychiatry.She is passionate about teaching and advocacy in women's mental health and serves as a member of the National Curriculum in Reproductive Psychiatry, where she helped spearhead a training program in women's mental health for psychiatrists across the country. Her clinical expertise is in helping individuals struggling with mood-related changes due to pregnancy, postpartum, infertility, reproductive loss, Polycystic Ovary Syndrome, premenstrual syndrome, and perimenopause.

Join America's Roundtable (https://americasrt.com/) radio co-hosts Natasha Srdoc and Joel Anand Samy with the Honorable Benjamin S. Carson, Sr. M.D., one of America's most principled leaders, a brilliant mind, and a champion of freedom. Dr. Ben Carson is the founder and chairman of the American Cornerstone Institute, the 17th U.S. Secretary of the Department of Housing and Development, and former director of pediatric neurosurgery at Johns Hopkins Hospital. The conversation focuses on: * Domestic and foreign policy initiatives with a review on the successes of the second Trump Administration. * The importance of faith, family and patriotism in protecting our freedoms in America. * The ills of marxism and socialism and their manifestation in America. * Expanding homeownership and reigniting the American Dream. * Affirming Israel's sovereignty and protecting Jewish communities in the West. Our conversation also highlights Dr. Ben Carson's must-read book "The Perilous Fight: Overcoming Our Culture's War on the American Family." Quote from Dr. Ben Carson's book, "The Perilous Fight": "The perilous fight" was penned by Francis Scott Key in the midst of a most difficult and pivotal moment in our nation's history when twenty British ships bombarded Fort McHenry from the Baltimore Harbor. It was on the morning of September 14, 1814 that Francis Scott Key wrote about the ramparts, and the land of the free and the home of the brave which inspired a nation and became a rallying victory call. “The perilous fight—those words arrest my attention whenever I place my right hand over my heart and face the flag at the playing of our national anthem. They are a reminder that America was born in a crucible of fire. Freedom was not given freely but had to be fought for and defended.” ~ Dr. Ben Carson Biography | Dr. Ben Carson In 1973, Ben Carson graduated from Yale University. He went on to receive his M.D. from the University of Michigan Medical School. At the age of 33, Dr. Carson became the chief of pediatric neurosurgery at Johns Hopkins Hospital, making him the youngest major division director in the hospital's history. This would be among an extensive list of outstanding firsts for Dr. Carson. Dr. Carson's accomplishments have earned him a place in medical history. He performed the first and only successful separation of craniopagus (Siamese) twins joined at the back of the head in 1987. He also performed the first fully successful separation of type-2 vertical craniopagus twins in 1997 in South Africa. In his career, Dr. Carson became a professor of neurosurgery, oncology, plastic surgery, and pediatrics at the Johns Hopkins School of Medicine, and directed pediatric neurosurgery at the Johns Hopkins Children's Center for over 29 years. In 2016, Dr. Carson accepted the position of Secretary of Housing and Urban Development under the Trump administration. After completing his tenure as the 17th Secretary of the Department of Housing and Urban Development in 2021, Dr. Carson founded the American Cornerstone Institute. This organization is focused on fighting for the principles that have guided him through life and that make this country great: faith, liberty, community and life. Dr. Carson and his wife, Candy Carson, co-founded the Carson Scholars Fund, which recognizes young people of all backgrounds for exceptional academic and humanitarian accomplishments. The organization has awarded more than 11,000 scholarships and paid out more than $8.9 million in scholarships. The Carson Scholars Fund is currently operating in 50 states and the District of Columbia, and since its founding, has installed more than 270 Ben Carson Reading Rooms around the country. In 2021, Dr. Carson founded the American Cornerstone Institute (ACI), a conservative think tank centered around advancing policies that promote “faith, liberty, community, and life.” Dr. and Mrs. Carson reside in Florida. They are the proud parents of three sons and three daughters-in-law, and blessed grandparents of eight grandchildren. Visit the American Cornerstone Institute's website (https://americancornerstone.org/) The American Cornerstone Institute is a 501(c)(3) non-profit organization founded in 2021 by Dr. Ben Carson that focuses on advancing America's founding principles of faith, liberty, community, and life. americasrt.com (https://americasrt.com/) https://ileaderssummit.org/ | https://jerusalemleaderssummit.com/ America's Roundtable on Apple Podcasts: https://podcasts.apple.com/us/podcast/americas-roundtable/id1518878472 Twitter: @RealBenCarson @ileaderssummit @AmericasRT @NatashaSrdoc @JoelAnandUSA @supertalk America's Roundtable is co-hosted by Natasha Srdoc and Joel Anand Samy, co-founders of International Leaders Summit and the Jerusalem Leaders Summit. America's Roundtable (https://americasrt.com/) radio program focuses on America's economy, healthcare reform, rule of law, security and trade, and its strategic partnership with rule of law nations around the world. The radio program features high-ranking US administration officials, cabinet members, members of Congress, state government officials, distinguished diplomats, business and media leaders and influential thinkers from around the world. Tune into America's Roundtable Radio program from Washington, DC via live streaming on Saturday mornings via 68 radio stations at 7:30 A.M. (ET) on Lanser Broadcasting Corporation covering the Michigan and the Midwest market, and at 7:30 A.M. (CT) on SuperTalk Mississippi — SuperTalk.FM reaching listeners in every county within the State of Mississippi, and neighboring states in the South including Alabama, Arkansas, Louisiana and Tennessee. Tune into WTON in Central Virginia on Sunday mornings at 6:00 A.M. (ET). Listen to America's Roundtable on digital platforms including Apple Podcasts, Spotify, Amazon, Google and other key online platforms. Listen live, Saturdays at 7:30 A.M. (CT) on SuperTalk | https://www.supertalk.fm

It's Tuesday, September 16th, A.D. 2025. This is The Worldview in 5 Minutes heard on 140 radio stations and at www.TheWorldview.com.  I'm Adam McManus. (Adam@TheWorldview.com) By Kevin Swanson Pakistani flood claims 900 lives Floods in Pakistan have taken the lives of 900 people. Plus, over two million people have been displaced and 1,600 villages destroyed. The British Christian Asian Association is on the ground helping Christian communities in Pakistan now.  Make a donation through a special link in our transcript today at www.TheWorldview.com.  Indicate in the box at the bottom of the linked page that your donation is to help the Pakistani flood victims. Trump compared Brazilian witch hunt of Bolsonaro to his trials As The Worldview reported on September 12th, Brazil's previous president, Jair Bolsonaro, was convicted of trying to overturn the 2022 election, and sentenced to 27 years in prison for it. U.S. President Donald Trump responded by comparing the ordeal with his own in 2020. He said, “I thought he was a good president of Brazil, and it's very surprising that could happen very much like they tried to do with me, but they didn't get away with it at all.” The Wall Street Journal featured a column by Mary O'Grady declaring that Brazil's courts have been turned to Lawfare — the use of the judicial system to achieve political ends.  Nepal's revolution leaves 51 dead and with new Prime Minister The nation of Nepal has been caught in a maelstrom of revolution for the past week, leaving 51 people dead, government buildings destroyed, and supermarkets and politician's homes burned to the ground, reports the BBC. The revolution was largely instigated by Gen Z, 18 to 24-year-old college-aged youth, after a social media ban. Nepal's prime minister resigned, and another was appointed — the first woman leader of the Himalayan country. The nation is relying upon Sushila Karki to restore stability.  She has promised $11,330 for each family where a protester was killed in the melee.   Similar youth-driven revolutions occurred in Sri Lanka in 2022 and Bangladesh in 2024, overturning these national governments as well. Isaiah 3:12 speaks of the instability of nations in similar terms. It says, “As for my people, children are their oppressors, and women rule over them. O my people, they which lead thee cause thee to err, and destroy the way of thy paths.” The nations of the world which have appointed or elected the most female leaders since 1946 are Finland, India, New Zealand, and England. The average number of nations led by female heads hovered around 6 in the 1990s and early 2000s. Today, the average has increased to 15 female leaders.  Utah Gov.: Kirk's murderer was “deeply indoctrinated with leftist ideology” Utah Republican Governor Spencer Cox has announced on CNN's State of the Union that official charges will be filed today against Charlie Kirk's alleged assassin, Tyler Robinson. The governor also said, “The FBI has confirmed that [Robinson's] roommate was a romantic partner, a male transitioning to female.”  Cox added that evidence from family and friends is pointing to the fact that the alleged murderer had been “deeply indoctrinated with leftist ideology.” Romans 1:28 and 29 speaks of the progression of evil: “And even as they did not like to retain God in their knowledge, God gave them over to a debased mind, to do those things which are not fitting; being filled with all unrighteousness, sexual immorality, wickedness, covetousness, maliciousness; full of envy, murder.” Tyler Robinson's trans roommate “hates conservatives and Christians” Fox News has also reported that Robinson's 22-year-old “trans roommate” "hates conservatives and Christians.” That according to an interview with a relative on Fox. The woman, who asked to remain anonymous, told Fox News Digital her relative began to act differently when he turned 18 and said that he developed a hatred of Christians and conservatives. She explained that “He hated us. He was not raised that way, but he, over the years, has become really detached [and] been radicalized. … He has obviously gotten progressively worse the last year or two.” Transgenderism on the rise Transgenderism has increased across the United States — with 1.6% of American adults claiming to be such. That's four million Americans!   Pew Research estimates that 44% of Americans know somebody who is attempting to appear to change their own gender. The Johns Hopkins Hospital in Baltimore, Maryland attempted the first gender mutilations back in 1966. The program was shut down in 1979. Then again, in 1997, the practice was reinstated by a Dr. Stanley Biber in Trinidad, Colorado. Biber's clinic became the gender mutilation capital of the country until the surgeon's retirement in 2003. These are the roots of the movement in America. Gold and stocks hit new highs Gold is reaching for new highs — scraping $3,670 per ounce on Monday. Silver reached $42.60 per ounce. That's up 41% and 38% respectively over the previous year. Stocks are up similarly. The NASDAQ reached 22,340 points yesterday, a 27% increase over last year. Meanwhile, the median house selling price has dropped a total of 7% since late 2022. Teen reels in 177-pound Halibut And finally, 13-year-old Jackson Denio of New Hampshire reeled in a 177-pound Atlantic Halibut  off the New England coast last week. That could be a world record for a youth catch. After wrestling with the fish for a half an hour on the line, it took three men to get the monster in the boat. DENIO: “It took the three deckhands and the captain to get it in the boat, and then, once it was in the boat, everybody was just yelling and cheering. FRIEND: “Jackson! Whoo!” The largest halibut on record weighed 515 pounds, caught in Alaska in 1996.  Close And that's The Worldview on this Tuesday, September 16th, in the year of our Lord 2025. Follow us on X or subscribe for free by Spotify, Amazon Music, or by iTunes or email to our unique Christian newscast at www.TheWorldview.com.  I'm Adam McManus (Adam@TheWorldview.com). Seize the day for Jesus Christ.

When Molly Hones was diagnosed with fibrolamellar cancer for the second time in less than two years, she made two critical decisions. First: She wouldn't focus on the unknowns of her condition and would focus on the positives instead.  Second, she would give back by participating in research. And so, in June 2023, Molly traveled to the Johns Hopkins Hospital, where oncologist and Conquer Cancer grant recipient Marina Baretti, MD, was running a clinical trial for people with fibrolamellar cancer. “I like to say I'm donating my body to science while I'm still alive,” Molly says. “And how cool is it to see my legacy when I'm still around?”  Which is how she found herself in Baltimore, Maryland, on the day she received an unthinkable phone call: Her husband Grant had passed away at age 45 from a brain aneurysm.   Even faced with such devastating news, Molly remained committed to moving forward with her treatment, connecting with other fibrolamellar patients, and celebrating life whenever she could. Being brave and facing challenges with a smile on her face, she says, is her way of honoring the people she's lost and the people she's met through her cancer journey.   In this episode of Your Stories, Molly speaks with host Dr. Mark Lewis about her experience with fibrolamellar cancer, the importance of community when facing a rare cancer, and her hopes of contributing to a world where every person with cancer can live life to the fullest. 

Join us as we delve into the evolving landscape of clinical trials in Latin America with Julio G. Martinez-Clark, CEO of BioAccess. Discover how his company is pioneering pathways for medtech innovators and shaping the future of medical device innovation in emerging markets.   Bioaccess® is a trailblazing company that's helped over 100 Medtech innovators navigate global clinical trials, and he currently serves as Ambassador of International Accrediting Organization for Clinical Research in the Americas. With a career that spans healthcare infrastructure, telecommunications, and regulatory strategy, Julio is a leading voice in the field of medical device innovation in emerging markets.   From his early days at Johns Hopkins Hospital to his current role in shaping ethical and efficient trial systems across Latin America, Julio's mission is clear: to expand access to high-quality research for patients and sponsors alike. He's also the host of the Global Trial Accelerators™ podcast, where he dives into trends in Medtech, Biopharma, Radiopharma and clinical trial innovation.   We unpack what makes Latin America a strategic region for clinical trials, especially for rare diseases, and explore how improving trial access can speed innovation, and change lives.   Episode Discussion Topics:    Introduction to Julio G. Martinez-Clark and his role at BioAccess. The clinical trial landscape in Latin America and its strategic importance. Julio's career journey from Johns Hopkins Hospital to BioAccess. The impact of cultural competence and community engagement on clinical trials. Challenges and solutions for conducting clinical trials during the pandemic. The role of artificial intelligence and digital tools in clinical trials. The future of clinical research in Latin America, including radiopharmaceuticals and theranostics. The importance of international standards and certifications for clinical research sites. Success stories and innovative approaches in clinical trials. Julio's podcast, Global Trial Innovators, and its focus on industry education. During the episode a blog post on bioaccess' website was referenced that highlights academic papers that talk about the higher recruitment and retention rates in Latin America, here it is: https://www.bioaccessla.com/blog/the-latin-american-advantage-why-clinical-trial-recruitment-and-retention-outpace-the-us-and-europe   Connect With Us:   Stay tuned for the next new episode of “It Happened To Me”! In the meantime, you can listen to our previous episodes on Apple Podcasts, Spotify, streaming on the website, or any other podcast player by searching, “It Happened To Me”.    “It Happened To Me” is created and hosted by Cathy Gildenhorn and Beth Glassman. DNA Today's Kira Dineen is our executive producer and marketing lead. Amanda Andreoli is our associate producer. Ashlyn Enokian is our graphic designer.   See what else we are up to on Twitter, Instagram, Facebook, YouTube and our website, ItHappenedToMePod.com. Questions/inquiries can be sent to ItHappenedToMePod@gmail.com. 

We are discussing perspective changes in neurology genetics with the crossover of the APOE gene in neuro and cardio as well as telehealth for neurology predictive testing. Segment 1: Is it time for a paradigm shift? Inclusion of APOE  on genetic dyslipidemia panels.   Emily Brown is a certified genetic counselor at the Center for Inherited Heart Disease at Johns Hopkins Hospital. She graduated from the University of Maryland Genetic Counseling Program in 2014 and has practiced in cardiology for the past 10 years. Her main areas of interest include dyslipidemias, and she is a member of the National Lipid Association.   Hannah Ison is a cardiovascular genetic counselor at the Stanford Center for Inherited Cardiovascular Disease. She received her Master's in Medical and Molecular Genetics from Indiana University in 2018, and returned home to California to begin her career. Her primary clinical interest includes working with patients who have inherited lipid conditions in both the adult and pediatric setting. A large part of her role has been focused on developing a Pediatric Lipid Clinic at the Stanford Children's Hospital, allowing her to care for patients across the generations. Hannah was the co-chair of the Dyslipidemia Working Group through the cardiovascular SIG from 2020-2024 where she worked with members to develop dyslipidemia resources. In addition to her work in the lipid space, she also provides inpatient and outpatient genetic counseling to patients with isolated congenital heart disease, and enjoys participating in various research opportunities.    In this segment we discuss: - APOE's relevance in both Alzheimer's and cardiovascular disease - Counseling strategies for APOE alleles (ε2, ε3, and ε4), including penetrance, lifestyle modification, and exploration of risk for conditions and symptoms external to Alzheimer's - Case studies highlighting APOE's diagnostic, variant, and treatment insights - The need for standardization, education, and reframing of APOE testing in practice Segment 2: Patient-reported outcomes for remote and in-person visits for genetic counseling in adult neurology.   Rachel A. Paul, MS, CGC and Laynie Dratch, ScM, CGC are board-certified genetic counselors who specialize in adult neurogenetics and work with the Penn Neurogenetics Therapy Center team in Philadelphia, PA (https://www.linkedin.com/company/penn-neurogenetics-therapy-center).   Rachel provides clinical and research genetic counseling services for the Division of Movement Disorders at the University of Pennsylvania. Her research interests include genetic screening for clinical trials access, remote/telemedicine genetic services, and motivations/barriers for genetics utilization. She graduated cum laude from Temple University in Philadelphia, previously worked as a genetic counseling assistant (GCA) for the Penn neurogenetics program, and completed her training with the Arcadia University (now University of Pennsylvania) Genetic Counseling Program.   Laynie's clinical focus includes frontotemporal degeneration (FTD) spectrum disorders, amyotrophic lateral sclerosis (ALS), and other neurodegenerative conditions. Her research interests include the lived experiences of at-risk individuals, predictive genetic testing considerations, and genetic counseling access and service delivery. She graduated summa cum laude from Colgate University with a BA in neuroscience and a minor in psychology, and completed her genetic counseling masters training at the Johns Hopkins University and the National Institutes of Health.   In this segment we discuss: - How COVID-19 pushed neurogenetics counseling from in-person to telehealth. - Why patient satisfaction stayed high across both formats, with video outperforming phone. - What drives visit preferences—travel, tech comfort, privacy, and clinical needs. - Future research to refine protocols, improve access, and explore broader applications.   Would you like to nominate a JoGC article to be featured in the show? If so, please fill out this nomination submission form here. Multiple entries are encouraged including articles where you, your colleagues, or your friends are authors.   Stay tuned for the next new episode of DNA Dialogues! In the meantime, listen to all our episodes Apple Podcasts, Spotify, streaming on the website, or any other podcast player by searching, “DNA Dialogues”.    For more information about this episode visit dnadialogues.podbean.com, where you can also stream all episodes of the show. Check out the Journal of Genetic Counseling here for articles featured in this episode and others.    Any questions, episode ideas, guest pitches, or comments can be sent into DNADialoguesPodcast@gmail.com.    DNA Dialogues' team includes Jehannine Austin, Naomi Wagner, Khalida Liaquat, Kate Wilson and DNA Today's Kira Dineen. Our logo was designed by Ashlyn Enokian. Our current intern is Stephanie Schofield.

Plus, the Audible version is also out at a reasonable price, far below that $10 I mistakenly stated. SHEESH! Do you like prior authorization requirements and "aggressive claim denials"? Well, neither does Johns Hopkins Hospital in Baltimore. That is the reason they may split from United Healthcare's networks in our Medicare Advantage Minute. In the "Your Medicare Benefits 2025" segment we learn what expenses Medicare will cover when it comes to organ transplants.                                                       The organs in question: heart, lung, kidney, intestine, liver & pancreas. The rest of the episode is filled with a glowing report on my new book, the most powerful book in all of Medicare: Medicare for the Lazy Man: BARE BONES!    Priced at $1 for the Kindle E-book, $4.60 for the paperback and the Audible book coming soon! Contact me at: DBJ@MLMMailbag.com (Most severe critic: A+)                   Visit us on: BabyBoomer.ORG Inspired by: "MEDICARE FOR THE LAZY MAN 2025; SIMPLEST & EASIEST GUIDE EVER!" "MEDICARE DRUG PLANS: A SIMPLE D-I-Y GUIDE" "MEDICARE FOR THE LAZY MAN: BARE BONES!" For sale on Amazon.com. After enjoying the books, please consider returning to leave a short customer review to  help future readers. Official website: https://www.MedicareForTheLazyMan.com.

In this continuation of their rich exchange, Sr. Ilia Delio and Dr. Iain McGilchrist explore the deeper dimensions of consciousness—and how our overreliance on the left hemisphere of the brain distorts our understanding of reality, relationships, and even God.Together, they reflect on:How attentiveness shapes the way we relate to the worldThe role of environment in forming perception and meaningWhy prayer, nature, and human relationships are vital to human flourishingThe distinction between brain and mind—and the mystery of consciousness itselfWhy the future depends not just on new tools, but on a renewed inner lifeWith clarity and conviction, Iain invites us to recover the neglected right brain, embrace relational knowing, and remember the divine ground that holds us. In a culture driven by certainty and efficiency, this episode points gently back toward wonder, prayer, and possibility.ABOUT IAIN MCGILCHRIST“What is required is an attentive response to something real and other than ourselves, of which we have only inklings at first, but which comes more and more into being through our response to it – if we are truly responsive to it. We nurture it into being; or not. In this it has something of the structure of love.”Dr. Iain McGilchrist is a psychiatrist, neuroscience researcher, philosopher and literary scholar. He is a Quondam Fellow of All Souls College, Oxford, an Associate Fellow of Green Templeton College, Oxford, a Fellow of the Royal College of Psychiatrists, and former Consultant Psychiatrist and Clinical Director at the Bethlem Royal & Maudsley Hospital, London. He has been a Research Fellow in neuroimaging at Johns Hopkins Hospital, Baltimore and a Fellow of the Institute of Advanced Studies in Stellenbosch. He has published original articles and research papers in a wide range of publications on topics in literature, philosophy, medicine and psychiatry. He is the author of a number of books, but is best-known for The Master and his Emissary: The Divided Brain and the Making of the Western World (Yale 2009). In November 2021 his two-volume work The Matter with Things: Our Brains, Our Delusions, and the Unmaking of the World was published by Perspectiva Press. www.channelmcgilchrist.comWhether you're enjoying Hunger for Wholeness or see ways we can improve, we'd genuinely value your feedback. Your insights help us serve our listening community with greater depth and clarity. Visit christogenesis.org/feedback to share your thoughts. Thanks for being part of the journey.Support the showA huge thank you to all of you who subscribe and support our show! Support for A Hunger for Wholeness comes from the Fetzer Institute. Fetzer supports a movement of organizations who are applying spiritual solutions to society's toughest problems. Get involved at fetzer.org. Visit the Center for Christogenesis' website at christogenesis.org/podcast to browse all Hunger for Wholeness episodes and read more from Ilia Delio. Follow us on Facebook and Instagram for episode releases and other updates.

To subscribe to our podcast and YouTube channel visit: https://www.youtube.com/@davisphinneyfdn/podcasts This episode of the Parkinson's Podcast features the full, unedited audio from a Live Well Today Webinar. In this episode, Dr. Greg Pontone discusses the effects that Parkinson's can have on mental health, including why mental health related symptoms occur, how they impact daily life, and what you can do to manage them.  You can view our library of past webinars and register to attend our next webinar at our website:  https://davisphinneyfoundation.org/event/live-well-today-webinars/ --- Speaker Bio:  Greg Pontone, MD, MHS is Division Chief and Professor Of Aging, Behavioral, and Cognitive Neurology at the University of Florida and Co-Director of Neuropsychiatry Program at The Norman Fixel institute for Neurological Diseases. Dr. Pontone earned his medical degree from the University of South Florida in Tampa. After medical school he completed a medical internship at Johns Hopkins Bayview followed by a residency in psychiatry and a fellowship in geriatric psychiatry and movement disorders research at The Johns Hopkins Hospital in Baltimore, Maryland.

Join us on this episode of "Braving Business" as we dive into the world of global entrepreneurship and personal resilience with Saville Kellner, CEO of Lake Industries. From his beginnings in Cape Town, South Africa, to building a multinational manufacturing and distribution empire, Saville shares the strategies and mindset shifts that propelled his ventures to success over the past four decades.Key topics include the growth of Lake Industries into a global powerhouse, the intricacies of running diverse companies like JLS Financial and Revenue Media Group, and the importance of adaptability in business. Saville opens up about his personal journey with Scleroderma, a condition he discovered through a friend, and how it has fueled his philanthropic efforts, including collaborations with The Johns Hopkins Hospital and organizing annual fundraising events.Listeners will gain valuable insights into balancing business leadership with meaningful philanthropy, understanding the significance of resilience in the face of personal and professional challenges, and the power of leveraging networks for global impact.Actionable Takeaways:Discover the principles of building a sustainable and globally recognized business.Learn how personal experiences can shape leadership styles and inspire philanthropic missions.Understand the importance of resilience and adaptability in navigating both business and personal trials.Gain practical advice on expanding your business network and influence across borders.Tune in to hear Saville Kellner's inspiring story and learn how to turn challenges into opportunities for growth and impact. Whether you're an entrepreneur, executive, or creative professional, this episode offers strategies to help you thrive in the face of adversity.Learn more about Saville at www.lakeindustries.com and www.revenuemediagroup.com

In this episode of Hunger for Wholeness, Sr. Ilia Delio engages renowned psychiatrist and author Dr. Iain McGilchrist. Together, they explore the profound implications of the brain's divided hemispheres—and how our overreliance on the left brain might be shaping Western culture in unexpected ways.What happens when we privilege abstract data over embodied experience? When mechanistic thinking crowds out emotional understanding and context? Drawing from his influential works The Master and His Emissary and The Matter with Things, Dr. McGilchrist proposes that the right hemisphere—long neglected—holds the key to restoring balance, wisdom, and connection in our lives and societies.Later in the episode, Sr. Ilia and Dr. McGilchrist discuss the nature of consciousness, the mystery of mind beyond brain, and the role of implicit knowing in liturgy, love, and the deepest human experiences.ABOUT IAIN MCGILCHRIST“What is required is an attentive response to something real and other than ourselves, of which we have only inklings at first, but which comes more and more into being through our response to it – if we are truly responsive to it. We nurture it into being; or not. In this it has something of the structure of love.”Dr. Iain McGilchrist is a psychiatrist, neuroscience researcher, philosopher and literary scholar. He is a Quondam Fellow of All Souls College, Oxford, an Associate Fellow of Green Templeton College, Oxford, a Fellow of the Royal College of Psychiatrists, and former Consultant Psychiatrist and Clinical Director at the Bethlem Royal & Maudsley Hospital, London. He has been a Research Fellow in neuroimaging at Johns Hopkins Hospital, Baltimore and a Fellow of the Institute of Advanced Studies in Stellenbosch. He has published original articles and research papers in a wide range of publications on topics in literature, philosophy, medicine and psychiatry. He is the author of a number of books, but is best-known for The Master and his Emissary: The Divided Brain and the Making of the Western World (Yale 2009). In November 2021 his two-volume work The Matter with Things: Our Brains, Our Delusions, and the Unmaking of the World was published by Perspectiva Press. www.channelmcgilchrist.comSupport the showA huge thank you to all of you who subscribe and support our show! Support for A Hunger for Wholeness comes from the Fetzer Institute. Fetzer supports a movement of organizations who are applying spiritual solutions to society's toughest problems. Get involved at fetzer.org. Visit the Center for Christogenesis' website at christogenesis.org/podcast to browse all Hunger for Wholeness episodes and read more from Ilia Delio. Follow us on Facebook, Instagram and Twitter for episode releases and other updates.

Thought leader Julio G. Martinez-Clark shares how his company in helping to bring medical innovation to the market sooner by conducting clinic trials in Latin America. About Julio: Julio G. Martinez-Clark stands at the forefront of clinical research transformation as the Ambassador of IAOCR/GCSA in the Americas and CEO of bioaccess®, where he bridges global quality standards with the world's growing MedTech, BioPharma, and Radiopharmaceutical ecosystems. With over two decades of cross-industry leadership spanning healthcare, telecommunications, and venture capital, Martinez-Clark has become the trusted partner for 100+ companies seeking accelerated regulatory approvals and cost-effective clinical trials worldwide. His unique fusion of technical expertise from Johns Hopkins Hospital infrastructure projects, regulatory acumen honed through UNESCO-aligned accreditations, and operational mastery of diverse global clinical trial landscapes positions him as the definitive authority on risk-mitigated medical innovation in emerging markets. Resources: Products discussed in the podcast: ReGelTec: https://regeltec.com/regeltec-chooses-colombia-bioacce-for-first-in-human-clinical-trial-of-hydrafil-system/   Spine Stabilization Technologies (SST): https://thespinemarketgroup.com/spinal-stabilization-technologies-ltd-announces-start-of-lopain-2-clinical-trial-in-south-america-for-lumbar-degenerative-disc-disease/   bioaccessla.com   Show sponsor:  The Cox 8 Table by Haven Medical

Learning Objectives:By the end of this series, listeners should be able to:Understand the research expectations of PICU Fellows in the United States.Explain the types of research available to PICU fellows and how a new fellow might explore their local options. Explain the work necessary to refine a research question and write mature specific aims for a project.  Understand the key factors involved in getting a fellowship paper submitted, including the common pitfalls for each type of research About our Guest: Mike Spaeder is a Professor of Pediatrics at the University of Virginia (UVA) School of Medicine and a pediatric critical care physician at the UVA Children's Hospital in Charlottesville, Virginia. He received his bachelor's degree in mathematics from Trinity College and his master's in statistics from George Washington University, where he also received his medical degree. He completed his pediatrics residency at Hasbro Children's Hospital/Brown University and his pediatric critical care fellowship at the Johns Hopkins Hospital. He is now the director of the Pediatric Critical Care fellowship at the UVA Children's Hospital. His research is based at the Center for Advanced Medical Analytics at the University of Virginia, where he focuses on modeling physiologic signatures of illness to identify patients at risk for clinical deterioration. Selected References:Horvat CM, Hamilton MF, Hall MW, McGuire JK, Mink RB Child Health Needs and the Pediatric Critical Care Medicine Workforce: 2020-2040. Pediatrics 2024 Feb 1 153Tasker RC. Writing for PCCM: The 3,000-Word Structured Clinical Research Report. Pediatr Crit Care Med. 2021 Mar 1;22(3):312-317.Sanchez-Pinto, L. Nelson MD, MBI1; Badke, Colleen M. MD, MS1; Pololi, Linda MBBS, FRCP (hon)2. Group Peer Mentoring: A Strategy to Promote Career Development and Improve Well-Being Among Early-Career Faculty in Pediatric Critical Care Medicine. Pediatric Critical Care Medicine ():10.1097/PCC.0000000000003763, May 15, 2025. | DOI: 10.1097/PCC.0000000000003763 Scott K. Radical Candor: Be a Kick-Ass Boss Without Losing Your Humanity. New York: St. Martin's Press; 2017. 1st ed. Equator Guidelines: https://www.equator-network.org/For Authors : Pediatric Critical Care MediQuestions, comments or feedback? Please send us a message at this link (leave email address if you would like us to relpy) Thanks! -Alice & ZacSupport the showHow to support PedsCrit:Please complete our Listener Feedback SurveyPlease rate and review on Spotify and Apple Podcasts!Donations are appreciated @PedsCrit on Venmo , you can also support us by becoming a patron on Patreon. 100% of funds go to supporting the show. Thank you for listening to this episode of PedsCrit. Please remember that all content during this episode is intended for educational and entertainment purposes only. It should not be used as medical advice. The views expressed during this episode by hosts and our guests are their own and do not reflect the official position of their institutions. If you have any comments, suggestions, or feedback-you can email us at pedscritpodcast@gmail.com. Check out http://www.pedscrit.com for detailed show notes. And visit @critpeds on twitter and @pedscrit on instagram for real time show updates.

Learning Objectives:By the end of this series, listeners should be able to:Understand the research expectations of PICU Fellows in the United States.Explain the types of research available to PICU fellows and how a new fellow might explore their local options. Explain the work necessary to refine a research question and write mature specific aims for a project.  Understand the key factors involved in getting a fellowship paper submitted, including the common pitfalls for each type of research About our Guest: Mike Spaeder is a Professor of Pediatrics at the University of Virginia (UVA) School of Medicine and a pediatric critical care physician at the UVA Children's Hospital in Charlottesville, Virginia. He received his bachelor's degree in mathematics from Trinity College and his master's in statistics from George Washington University, where he also received his medical degree. He completed his pediatrics residency at Hasbro Children's Hospital/Brown University and his pediatric critical care fellowship at the Johns Hopkins Hospital. He is now the director of the Pediatric Critical Care fellowship at the UVA Children's Hospital. His research is based at the Center for Advanced Medical Analytics at the University of Virginia, where he focuses on modeling physiologic signatures of illness to identify patients at risk for clinical deterioration. Selected References:Horvat CM, Hamilton MF, Hall MW, McGuire JK, Mink RB Child Health Needs and the Pediatric Critical Care Medicine Workforce: 2020-2040. Pediatrics 2024 Feb 1 153Tasker RC. Writing for PCCM: The 3,000-Word Structured Clinical Research Report. Pediatr Crit Care Med. 2021 Mar 1;22(3):312-317.Sanchez-Pinto, L. Nelson MD, MBI1; Badke, Colleen M. MD, MS1; Pololi, Linda MBBS, FRCP (hon)2. Group Peer Mentoring: A Strategy to Promote Career Development and Improve Well-Being Among Early-Career Faculty in Pediatric Critical Care Medicine. Pediatric Critical Care Medicine ():10.1097/PCC.0000000000003763, May 15, 2025. | DOI: 10.1097/PCC.0000000000003763 Scott K. Radical Candor: Be a Kick-Ass Boss Without Losing Your Humanity. New York: St. Martin's Press; 2017. 1st ed. Equator Guidelines: https://www.equator-network.org/For Authors : Pediatric Critical Care MediQuestions, comments or feedback? Please send us a message at this link (leave email address if you would like us to relpy) Thanks! -Alice & ZacSupport the showHow to support PedsCrit:Please complete our Listener Feedback SurveyPlease rate and review on Spotify and Apple Podcasts!Donations are appreciated @PedsCrit on Venmo , you can also support us by becoming a patron on Patreon. 100% of funds go to supporting the show. Thank you for listening to this episode of PedsCrit. Please remember that all content during this episode is intended for educational and entertainment purposes only. It should not be used as medical advice. The views expressed during this episode by hosts and our guests are their own and do not reflect the official position of their institutions. If you have any comments, suggestions, or feedback-you can email us at pedscritpodcast@gmail.com. Check out http://www.pedscrit.com for detailed show notes. And visit @critpeds on twitter and @pedscrit on instagram for real time show updates.

Pria Anand speaks to managing editor Emily Everett about her story “The Elephant's Child,” which appears in The Common's spring issue. The piece is a vivid retelling of a Hindu myth, the origin story of the elephant-headed god Ganesh. Pria talks about the process of writing and revising many versions of this ancient myth, why she felt inspired by it, and how her literary writing intersects with her career as a neurologist. Pria also discusses her debut book, The Mind Electric: A Neurologist on the Strangeness and Wonder of Our Brains, out this month from Simon & Schuster. The book explores how story and storytelling can illuminate the rich, complex gray areas within the science of the brain, weaving case study, history, fable, and memoir. Pria Anand is a neurologist and the author of The Mind Electric, out from Simon & Schuster in the U.S. and Little, Brown in the U.K. Her stories and essays have appeared in the Los Angeles Review of Books, Time Magazine, The Boston Globe, The Washington Post, The New York Times, Ploughshares, and elsewhere. She is a graduate of Yale University and Stanford Medical School, and she trained in neurology, neuro-infectious diseases, and neuroimmunology at the Johns Hopkins Hospital and the Massachusetts General Hospital. She is now an Assistant Professor of Neurology at the Boston University School of Medicine, and she cares for patients at the Boston Medical Center. ­­Read Prias's story “The Elephant's Child” in The Common at thecommononline.org/the-elephants-child. Order The Mind Electric in all formats via Simon & Schuster at simonandschuster.com/books/The-Mind-Electric/. Learn more about Pria at www.priaanand.com. The Common is a print and online literary magazine publishing stories, essays, and poems that deepen our collective sense of place. On our podcast and in our pages, The Common features established and emerging writers from around the world. Read more and subscribe to the magazine at thecommononline.org, and follow us on Instagram, Bluesky, and Facebook. Emily Everett is managing editor of the magazine and host of the podcast. Her new debut novel All That Life Can Afford is the Reese's Book Club pick for April 2025. Her work has appeared in The New York Times Modern Love column, the Kenyon Review, Electric Literature, Tin House, and Mississippi Review. She was a 2022 Massachusetts Cultural Council Fellow in Fiction. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

Pria Anand speaks to managing editor Emily Everett about her story “The Elephant's Child,” which appears in The Common's spring issue. The piece is a vivid retelling of a Hindu myth, the origin story of the elephant-headed god Ganesh. Pria talks about the process of writing and revising many versions of this ancient myth, why she felt inspired by it, and how her literary writing intersects with her career as a neurologist. Pria also discusses her debut book, The Mind Electric: A Neurologist on the Strangeness and Wonder of Our Brains, out this month from Simon & Schuster. The book explores how story and storytelling can illuminate the rich, complex gray areas within the science of the brain, weaving case study, history, fable, and memoir. Pria Anand is a neurologist and the author of The Mind Electric, out from Simon & Schuster in the U.S. and Little, Brown in the U.K. Her stories and essays have appeared in the Los Angeles Review of Books, Time Magazine, The Boston Globe, The Washington Post, The New York Times, Ploughshares, and elsewhere. She is a graduate of Yale University and Stanford Medical School, and she trained in neurology, neuro-infectious diseases, and neuroimmunology at the Johns Hopkins Hospital and the Massachusetts General Hospital. She is now an Assistant Professor of Neurology at the Boston University School of Medicine, and she cares for patients at the Boston Medical Center. ­­Read Prias's story “The Elephant's Child” in The Common at thecommononline.org/the-elephants-child. Order The Mind Electric in all formats via Simon & Schuster at simonandschuster.com/books/The-Mind-Electric/. Learn more about Pria at www.priaanand.com. The Common is a print and online literary magazine publishing stories, essays, and poems that deepen our collective sense of place. On our podcast and in our pages, The Common features established and emerging writers from around the world. Read more and subscribe to the magazine at thecommononline.org, and follow us on Instagram, Bluesky, and Facebook. Emily Everett is managing editor of the magazine and host of the podcast. Her new debut novel All That Life Can Afford is the Reese's Book Club pick for April 2025. Her work has appeared in The New York Times Modern Love column, the Kenyon Review, Electric Literature, Tin House, and Mississippi Review. She was a 2022 Massachusetts Cultural Council Fellow in Fiction. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/literary-studies

Dr. Christopher Smith is a Board-Certified practicing physician who completed his residency and fellowship at the world-renowned Johns Hopkins Hospital. Dr. Smith currently lives in Pennsylvania and is a partner with Quantum Imaging and Therapeutic Associates. He dedicates time and resources to raising awareness of homeless children and finding solutions to help them overcome their situation. “Around the age of four, there was a big turning point in my life. My father lost his job at the steel mill. After that my parents struggled financially for the rest of my teenage years. We really had difficulty maintaining housing and lived for months at a time without basic utilities like heat or electricity. “By the time I was 16, my family and I had moved at least a couple dozen times. That year my family got evicted one more time and we had nowhere to go. It was my senior year of high school. My parents and 6 of my siblings stayed in a small motel room. I slept in the truck the entire year, and this was in Utah. It was so cold in winter that sometimes my hair would actually freeze at night. “But I had decided that there was no shortcut in life. I had to work through it and through all these difficult circumstances. I was willing to take risks. I made mistakes. I failed. But that was okay. I kept trying. That's part of the experience, the process and the idea of not quitting when you fail. "A lot of years of my life were very difficult, but I always tried to maintain a positive outlook on my life.  I still always try to see potential, the good in the world now. “The statistical odds of me going from sleeping in a truck as a teenager to completing my medical degree at Johns Hopkins Hospital are so astronomically high that I personally think there was some intervention in my life, somebody looking out for me with the purpose of helping me view my past in a different light and of being able to share that with other people, inspiring them to learn from my past. That was my ultimate reason for writing the book Homeless to Hopkins and a children's version because children in poverty are often the most invisible homeless people of all.”

We just celebrated Mother's Day, which may not have been what you expected. It can be a complicated day when people don't show up or recognize you as you deserve. I want to acknowledge the complex feelings that come with Mother's Day and say that you aren't alone in experiencing those emotions. Whatever your Mother's Day brought you, I hope you feel recognized and supported. Today, we are bringing you another great episode during Maternal Mental Health Month as we uncover the purpose of a new podcast filling a gap for many people. Join us to learn more about this vital resource! Allie Hales, a mom of four, is passionate about making reliable, relevant information available for moms like herself. She graduated from the J. Reuben Clark Law School at Brigham Young University and is a member of the Massachusetts Bar. She serves on Brigham and Women's Hospital's Newborn Medicine and Reproductive Health Advisory Board, Newton-Wellesley Hospital's Maternal Services Council, and is actively involved with the Boston Center for Endometriosis. Allie grew up in the suburbs of Boston and currently lives in Baltimore with her four children and her husband, Riley, a resident in anesthesia at Johns Hopkins Hospital.  Dr. Ruta Nonacs completed a perinatal and reproductive psychiatry fellowship at Massachusetts General Hospital. She is a clinical instructor at Harvard Medical School, a senior psychiatrist with the Center for Women's Mental Health at Massachusetts General Hospital, and the creator and editor-in-chief of their website,⁠ ⁠⁠womensmentalhealth.org⁠. She, with Allie Hales, co-hosts the new podcast,⁠ So Glad You Asked⁠. Dr. Ruta's work has been published in numerous scientific journals and books, and she is the author of⁠ A Deeper Shade of Blue: A Woman's Guide to Recognizing and Treating Depression in Her Childbearing Years. ⁠ Show Highlights: Highlights of Dr. Ruta's path to her current work Allie's lived experience in her mental health journey and her connection to Dr. Ruta Barriers to getting information and accessing treatment The importance of lived experience in developing solutions and strategies Moms, questions, and a new podcast Giving a voice to “regular moms” and providing evidence-based solutions Major topics planned for upcoming podcast episodes (Dr. Ruta and Allie have a huge list!) The connection between the podcast and a resource hub at ⁠womensmentalhealth.org⁠ Accessible information IS preventative. The podcast schedule and plans for the first season Dr. Ruta and Allie's hopes and dreams for their podcast to empower and support women Resources: Connect with Dr. Ruta Nonacs and Allie Hales:⁠ Women's Mental Health website⁠,⁠ Instagram⁠,⁠ So Glad You Asked⁠ podcast, and⁠ A Deeper Shade of Blue: A Woman's Guide to Recognizing and Treating Depression in Her Childbearing Years⁠. Call the National Maternal Mental Health Hotline at 1-833-TLC-MAMA or visit⁠ cdph.ca.gov⁠ Please find resources in English and Spanish at⁠ Postpartum Support International⁠, or by phone/text at 1-800-944-4773. There are many free resources, like online support groups, peer mentors, a specialist provider directory, and perinatal mental health training for therapists, physicians, nurses, doulas, and anyone who wants to be more supportive in offering services.  You can also follow PSI on social media:⁠ Instagram⁠,⁠ Facebook⁠, and most other platforms Visit⁠ www.postpartum.net/professionals/certificate-trainings/⁠ for information on the grief course.   Visit my website,⁠ www.wellmindperinatal.com⁠, for more information, resources, and courses you can take today! If you are a California resident looking for a therapist in perinatal mental health, ⁠email me⁠ about openings for private pay clients! Learn more about your ad choices. Visit podcastchoices.com/adchoices

Are Vaccines Good For Us? Marschall S. Runge, M.D., Ph.D., was born in Austin, Texas, and graduated from Vanderbilt University with a BA in General Biology and a PhD in Molecular Biology. He received his medical degree from the Johns Hopkins School of Medicine and trained in internal medicine at Johns Hopkins Hospital. He was a cardiology fellow and junior faculty member at Massachusetts General Hospital. Dr. Runge's next position was at Emory University, where he directed the Cardiology Fellowship Training Program. He then moved to the University of Texas Medical Branch in Galveston, where he was Chief of Cardiology and Director of the Sealy Center for Molecular Cardiology. He joined the University of North Carolina (UNC) from 2000 – 2014, where he served as Charles Addison and Elizabeth Ann Sanders Distinguished Professor of Medicine, Chair of the Department of Medicine, President of UNC Physicians and Vice Dean for Clinical Affairs. Dr. Runge visits with Mark Alyn.Become a supporter of this podcast: https://www.spreaker.com/podcast/late-night-health-radio--2804369/support.

For the past 150 years, the power players in Washington D.C. have been using Johns Hopkins University to outsource their dangerous research and development projects. The School of Medicine and the Johns Hopkins Hospital have been in operation for over a century, and their connections to Big Pharma, the World Health Organization, and the military are well documented. The Center For Health Security has been running bioterrorism drills for the past two decades simulating influenza pandemics, aerosolized smallpox, and powdered anthrax attacks. Best known for Event 201 in October of 2019, their ability to predict the future is alarming and screams “advanced knowledge”. The Octopus of Global Control Audiobook: https://amzn.to/3xu0rMm Hypocrazy Audiobook: https://amzn.to/4aogwms Website: www.Macroaggressions.io Activist Post: www.activistpost.com Sponsors: Chemical Free Body: https://www.chemicalfreebody.com Promo Code: MACRO C60 Purple Power: https://c60purplepower.com/ Promo Code: MACRO Wise Wolf Gold & Silver: www.Macroaggressions.gold LegalShield: www.DontGetPushedAround.com EMP Shield: www.EMPShield.com Promo Code: MACRO ECI Development: https://info.ecidevelopment.com/-get-to-know-us/macro-aggressions Christian Yordanov's Health Transformation Program: www.LiveLongerFormula.com Privacy Academy: https://privacyacademy.com/step/privacy-action-plan-checkout-2/?ref=5620 Brain Supreme: www.BrainSupreme.co Promo Code: MACRO Above Phone: http://abovephone.com/?above=macro Promo Code: MACRO Van Man: www.VanMan.shop Promo Code: MACRO Activist Post: www.ActivistPost.com Natural Blaze: www.NaturalBlaze.com Link Tree: https://linktr.ee/macroaggressionspodcast

Dr. Ben Carson is an American retired neurosurgeon, author, and politician who served as the 17th United States Secretary of Housing and Urban Development from 2017 to 2021. As a pioneering pediatric neurosurgeon at Johns Hopkins Hospital, Carson performed groundbreaking surgeries, including the first successful separation of conjoined twins joined at the back of the head, the first successful neurosurgical procedure on a fetus inside the womb, and developed new methods to treat brain-stem tumors. He retired from medicine in 2013 after a distinguished career that included over 100 neurosurgical publications and numerous awards, including the Presidential Medal of Freedom. As HUD Secretary, Carson oversaw initiatives such as the expansion of the Rental Assistance Demonstration program, the establishment of the White House Opportunity and Revitalization Council, and efforts to reduce veteran homelessness. Following his departure from HUD, Carson founded the American Cornerstone Institute (ACI) in 2021, a conservative think tank centered around advancing policies that promote faith, liberty, community, and life. He also founded Carson Scholars and Little Patriots Learning to directly support excellence in education for young thinkers. Carson continues to be an influential figure in conservative politics and public policy discussions. Shawn Ryan Show Sponsors: https://ShawnLikesGold.com | 855-936-GOLD #goldcopartner https://amac.us/srs https://bubsnaturals.com/shawn https://americanfinancing.net/srs | 866-781-8900 NMLS 182334, nmlsconsumeraccess.org. APR for rates in the 5s start at 6.327% for well qualified borrowers. Call 866-781 8900 for details about credit costs and terms. https://meetfabric.com/shawn https://helixsleep.com/srs https://preparewithshawn.com https://rocketmoney.com/srs https://shopify.com/srs https://hexclad.com/srs #hexcladpartner This episode is sponsored by BetterHelp. Give online therapy a try at betterhelp.com/srs and get on your way to being your best self. Ben Carson Links: Instagram - https://www.instagram.com/realbencarson X - https://x.com/RealBenCarson American Cornerstone Institute - https://americancornerstone.org Little Patriots Learning - https://littlepatriotslearning.com Carson Scholars -https://carsonscholars.org YouTube - https://www.youtube.com/channel/UCxWET2F0fctmIwnGUP_8FMw Learn more about your ad choices. Visit podcastchoices.com/adchoices

Peter Attia, MD, is a Canadian-American physician, author, and researcher specializing in longevity medicine. He received his medical degree from Stanford University, trained in general surgery at Johns Hopkins Hospital, and completed a surgical oncology fellowship at the National Cancer Institute. Attia is the founder of Early Medical, a medical practice focused on extending lifespan and healthspan, and hosts "The Drive," a popular podcast covering health and medicine topics. Attia is the author of the #1 New York Times bestseller "Outlive: The Science and Art of Longevity," published in March 2023. Attia has been featured in various media outlets, including the Disney+ documentary series "Limitless" with Chris Hemsworth. He is a sought-after speaker, appearing at events such as TEDMED and SXSW, where he discusses longevity science and proactive health strategies. Attia was named in Time's 2024 list of influential people in health and opened 10 Squared, a hybrid testing lab and training center in Austin, Texas. Shawn Ryan Show Sponsors: https://ShawnLikesGold.com | 855-936-GOLD #goldcopartner https://tryarmra.com/srs https://patriotmobile.com/srs | 972-PATRIOT Head to https://lumen.me/srs for 20% off your purchase. https://ziprecruiter.com/srs https://ROKA.com - USE CODE "SRS" https://babbel.com/srs Upgrade your wardrobe and save on trueclassic at trueclassic.com/srs #trueclassicpod https://betterhelp.com/srs https://drinkhoist.com - USE CODE "SRS" Peter Attia Links: Website - https://peterattiamd.com Instagram - https://www.instagram.com/peterattiamd X - https://x.com/PeterAttiaMD Facebook - https://www.facebook.com/peterattiamd YouTube - https://www.youtube.com/c/PeterAttiaMD Early Medical - https://earlymedical.com The Drive Podcast - https://peterattiamd.com/podcast 10 Squared - https://10squared.com Learn more about your ad choices. Visit podcastchoices.com/adchoices

​​Ever wonder why some of the smartest people, like doctors, can still get it wrong? In this eye-opening episode, Gabe Howard talks with Dr. Marty Makary, author of “Blind Spots: When Medicine Gets It Wrong,” to uncover how groupthink and cognitive biases influence not just medicine but also parenting and our everyday decisions. In this episode, Dr. Makary reveals why questioning authority is essential for better health outcomes. Parents, this episode is a must-listen! Learn why you don't need to follow the crowd when it comes to screen time, added sugar, and more. Packed with fascinating insights, this conversation challenges what you think you know about health, medicine, and parenting—and might just change how you see the world. “Maybe adults have done this to children? We have induced this problem. We have to look at our poisoned food supply. These engineered addictive food chemicals that are added, the role of pesticides, how we're changing the microbiome, throwing antibiotics loosely at people. Maybe we need to talk about school lunch programs, not just putting every kid on Ozempic? Maybe we need to talk about screen time addiction and its dopamine surge, not just putting every kid on medications?” ~Marty Makary, MD To learn more -- or read the transcript -- please visit the official episode page. Our guest, Dr. Marty Makary, is a New York Times bestselling author and health care expert at Johns Hopkins University. He writes for The Wall Street Journal and served in leadership at the World Health Organization. Marty is the recipient of the 2020 Business Book of the Year Award for his book, “The Price We Pay,” which has been described by Steve Forbes as “A must-read for every American.” A public health researcher, Dr. Makary leads efforts to improve the health of communities and focuses on the “redesign of healthcare” to make healthcare more reliable, holistic, and coordinated, especially for vulnerable populations. He leads national efforts to increase medical transparency and lower health care costs for everyday businesses and consumers. Clinically, Dr. Makary is the chief of Islet Transplant Surgery at Johns Hopkins and is the recipient of the Nobility in Science Award from the National Pancreas Foundation. He has been a visiting professor at over 25 medical schools, has published over 250 peer-reviewed scientific articles, and has been elected to the National Academy of Medicine. A graduate of Bucknell, Thomas Jefferson, and Harvard Universities, he completed his surgical residency at Georgetown University and his specialty training at Johns Hopkins Hospital. Our host, Gabe Howard, is an award-winning writer and speaker who lives with bipolar disorder. He is the author of the popular book, "Mental Illness is an Asshole and other Observations," available from Amazon; signed copies are also available directly from the author. Gabe is also the host of the "Inside Bipolar" podcast with Dr. Nicole Washington. Gabe makes his home in the suburbs of Columbus, Ohio. He lives with his supportive wife, Kendall, and a Miniature Schnauzer dog that he never wanted, but now can't imagine life without. To book Gabe for your next event or learn more about him, please visit gabehoward.com. Learn more about your ad choices. Visit megaphone.fm/adchoices